{"text": "Results : An estimated 10.5 million adults annually reported past year non - medical use ( NMU ) of prescription pain medications , and 39 % , or 4.1 million adults annually , also reported one or more past year ED visits .", "label": "", "metadata": {}, "score": "48.390446"}
{"text": "Table 1 .Characteristics of cases and controls .Values are numbers ( percentages ) unless stated otherwise .Seventeen ( 28 % ) cases and 26 ( 12 % ) controls were current users of the drospirenone oral contraceptive .", "label": "", "metadata": {}, "score": "55.230263"}
{"text": "In secondary analyses , individuals with more frequent NMU had increased odds of ED utilization in unadjusted analyses , but this association was attenuated with adjustment for the source of prescription pain medication ( i.e. , physician , friend / family , other source ) .", "label": "", "metadata": {}, "score": "56.369087"}
{"text": "The results reported by Samanic et al . , 2006 showed obese men had significantly lower risk of multiple myeloma compared to men of normal weight ( RR 0.58 ; 95 % confidence interval 0.36 to 0.93 ) .", "label": "", "metadata": {}, "score": "57.426758"}
{"text": "Opioid prescription , street , and combination ( street + prescription ) users completed the Addiction Severity Index multiple times over the course of one treatment year .", "label": "", "metadata": {}, "score": "58.19934"}
{"text": "The crude incidence rates were 23.0 ( 95 % confidence interval 13.4 to 36.9 ) and 9.1 ( 6.6 to 12.2 ) per 100 000 woman years in current users of drospirenone and levonorgestrel oral contraceptives .", "label": "", "metadata": {}, "score": "58.206276"}
{"text": "Among first time users , the unmatched odds ratio from the interaction model adjusted for the matching factors and body mass index was 8.6 ( 1.7 to 42.8 ) .", "label": "", "metadata": {}, "score": "58.372143"}
{"text": "This database has been used previously in several studies of oral contraceptive use and venous thromboembolism .3 5 7 It contains information derived from the general practice records of more than three million people in the United Kingdom , including demographic data and details of prescribed drugs , medical diagnoses , hospital admissions , and deaths .", "label": "", "metadata": {}, "score": "58.792316"}
{"text": "The pooled risk ratio demonstrated that obese women had an increased risk of postmenopausal breast cancer compared to women of normal weight ( RR , 1.25 ; 95 % confidence interval 1.07 to 1.46 ) .", "label": "", "metadata": {}, "score": "58.88199"}
{"text": "The crude incidence rate was 23.0 ( 95 % confidence interval 13.4 to 36.9 ) per 100 000 woman years in current users of drospirenone and 9.1 ( 6.6 to 12.2 ) per 100 000 woman years in current users of levonorgestrel oral contraceptives .", "label": "", "metadata": {}, "score": "59.79226"}
{"text": "The pooled risk ratio illustrated that obese men had an increased risk of gallbladder cancer compared to normal weight men ( RR 1.47 ; 95 % confidence interval 1.17 to 1.85 ) .", "label": "", "metadata": {}, "score": "59.894554"}
{"text": "The odds ratio adjusted for body mass index was 3.3 ( 1.4 to 7.6 ) .Further adjustment for a history of varicose veins , smoking , and the use of antidepressants ( any antidepressant or tricyclic and non - tricyclic antidepressants separately ) had a negligible effect ; the odds ratio was 3.1 ( 1.3 to 7.5 ) .", "label": "", "metadata": {}, "score": "59.903603"}
{"text": "The age adjusted incidence rate ratio was 2.7 ( 1.5 to 4.7 ) .Discussion .In this study , women who were current users of the oral contraceptive containing drospirenone were about three times as likely to develop non - fatal idiopathic venous thromboembolism as were current users of contraceptives containing levonorgestrel .", "label": "", "metadata": {}, "score": "60.199112"}
{"text": "The pooled risk ratio illustrated that obese men had no increased risk of thyroid cancer compared to men of normal weight ( RR 1.12 ; 95 % confidence interval 0.72 to 1.72 ) .", "label": "", "metadata": {}, "score": "60.35257"}
{"text": "There were no differences for the remaining eleven cancers on the relationship between obesity and cancer in women .The second important difference between the two meta - analyses concerns the observed magnitude of the association and the coinciding 95 % confidence intervals .", "label": "", "metadata": {}, "score": "61.051388"}
{"text": "Two other studies found a small increase in risk of venous thromboembolism in users of the drospirenone oral contraceptive when compared with levonorgestrel .10 11 In a Danish registry based cohort study , the relative risk was 1.64 ( 95 % confidence interval 1.27 to 2.10 ) .", "label": "", "metadata": {}, "score": "61.12782"}
{"text": "Unlike the Danish cohort study , 10 we were able to exclude women with temporary risk factors for venous thromboembolism , such as surgery , injury , and immobility , and to explore the influence of body mass index and smoking .", "label": "", "metadata": {}, "score": "61.277977"}
{"text": "To be included in the study , current users had to have at least one year of recorded medical information before the index date .We defined the current episode of use as the continuous episode of oral contraceptive use that led up to the index date .", "label": "", "metadata": {}, "score": "62.400642"}
{"text": "Fourteen ( 23 % ) cases and 36 ( 17 % ) controls had no record of any previous oral contraceptive use before the current episode .", "label": "", "metadata": {}, "score": "62.549114"}
{"text": "Fourthly , we restricted the study to current users of drospirenone and levonorgestrel contraceptives who received prescriptions from their general practitioners .We used multiple imputation methods to impute missing data for body mass index and smoking ; although this assumes that data are missing at random , non - ignorable mechanisms that would have had more than a minimal effect on the estimated odds ratios are unlikely .", "label": "", "metadata": {}, "score": "62.62237"}
{"text": "This strategy incorporates the risk of those who have a BMI slightly above normal , to above normal to those identified as obese .Given the risk of developing cancer at lower BMI levels is generally less than that of obese persons which provides some explanation why Renehan et al 's results generally illustrate lower overall risk and more narrow confidence intervals .", "label": "", "metadata": {}, "score": "62.650566"}
{"text": "We found elevated risks in the periods before and after January 2007 .The odds ratios from the interaction model ( adjusted for body mass index ) were 2.2 ( 0.5 to 9.2 ) in the first period and 4.1 ( 1.4 to 11.8 ) in the second period ; the P value for the interaction was 0.5 .", "label": "", "metadata": {}, "score": "62.752758"}
{"text": "As with cases , potential controls had to be current users of a study oral contraceptive and to have had at least one year of recorded medical information before the index date .", "label": "", "metadata": {}, "score": "62.789352"}
{"text": "Sixteen studies were included in the meta - analysis assessing the association between obesity and colon cancer among men ( Figure 2(a ) ) and 13 studies among women ( Figure 2(b ) ) .", "label": "", "metadata": {}, "score": "62.85316"}
{"text": "In the case - control analysis , current use of the drospirenone contraceptive was associated with a threefold higher risk of non - fatal idiopathic venous thromboembolism compared with levonorgestrel use ; the odds ratio adjusted for body mass index was 3.3 ( 95 % confidence interval 1.4 to 7.6 ) .", "label": "", "metadata": {}, "score": "63.032093"}
{"text": "The pooled risk ratio illustrated that obese men had an increased risk of renal cancer compared to men of normal weight ( RR 1.57 ; 95 % confidence interval 1.38 to 1.77 ) .", "label": "", "metadata": {}, "score": "63.11338"}
{"text": "We thus included 61 cases in the study ; 27 had a diagnosis of deep vein thrombosis alone , and 34 had pulmonary embolism .The mean age was 32.2 years for the cases and 31.8 years for the controls .", "label": "", "metadata": {}, "score": "63.321877"}
{"text": "Setting UK General Practice Research Database .Participants Women aged 15 - 44 years without major risk factors for venous thromboembolism who started a new episode of use of an oral contraceptive containing 30 \u00b5g oestrogen in combination with either drospirenone or levonorgestrel between May 2002 and September 2009 .", "label": "", "metadata": {}, "score": "63.41221"}
{"text": "Our meta - analysis therefore did not incorporate into the pooled risk ratio and 95 % confidence intervals , the risk associated with developing cancer among those with slightly above normal and above normal BMI .", "label": "", "metadata": {}, "score": "63.429787"}
{"text": "The P value for the interaction was 0.17 .We also did a matched analysis to examine whether the excess risk of venous thromboembolism in current users of the drospirenone contraceptive differed according to the elapsed time since the product had been introduced on to the market .", "label": "", "metadata": {}, "score": "63.5502"}
{"text": "Similarly , among obese women the pooled risk ratio illustrated an increased risk of renal cancer compared to women of normal weight ( RR 1.72 ; 95 % confidence interval 1.58 to 1.88 ) .", "label": "", "metadata": {}, "score": "63.978725"}
{"text": "There was no significant heterogeneity across studies ( heterogeneity . )The pooled risk ratio for obese women showed no increased risk of malignant melanoma compared to women of normal weight ( RR 0.95 ; 95 % confidence interval 0.84 to 1.07 ) .", "label": "", "metadata": {}, "score": "64.11327"}
{"text": "11 , pp .1435 - 1440 , 2000 .View at Google Scholar \u00b7 View at Scopus \" We also specified two additional patient - reported measures that were deemed potentially relevant to ED utilization among individuals using prescription pain medications non - medically , ( 1 ) source of prescription pain medications used nonmedically , and ( 2 ) past year opioid withdrawal symptoms .", "label": "", "metadata": {}, "score": "64.35721"}
{"text": "Likewise , among obese women the pooled risk ratio demonstrated no increased risk of thyroid cancer compared to women of normal weight ( RR 1.03 ; 95 % confidence interval 0.87 to 1.23 ) .", "label": "", "metadata": {}, "score": "64.50018"}
{"text": "There was no significant heterogeneity across studies ( heterogeneity . )The pooled risk ratio illustrated that obese women had an increased risk of colon cancer compared to women of normal weight ( RR 1.19 ; 95 % confidence interval 1.04 to 1.36 ) .", "label": "", "metadata": {}, "score": "64.645"}
{"text": "We also explored the effect of the duration of the current episode of oral contraceptive use .We retained adjustment for body mass index in all models ; we included other variables if they were significant predictors or if their inclusion altered the odds ratio for the association with type of oral contraceptive by more than 10 % .", "label": "", "metadata": {}, "score": "65.23158"}
{"text": "There was no significant heterogeneity across studies ( heterogeneity . )Among obese women , however , the pooled risk ratio showed a reduced risk of non - Hodgkin lymphoma compared to women of normal weight ( RR 0.91 ; 95 % confidence interval 0.86 to 0.97 ) .", "label": "", "metadata": {}, "score": "65.538086"}
{"text": "For obese women , however , the pooled risk ratio illustrated an increased risk of leukemia compared to women of normal weight ( RR 1.32 ; 95 % confidence interval 1.08 to 1.60 ) .", "label": "", "metadata": {}, "score": "65.56301"}
{"text": "In any event , we found an elevated risk for validated cases .Comparison with other studies .Our finding of a higher risk of non - fatal venous thromboembolism in users of oral contraceptives containing drospirenone , relative to levonorgestrel users , is consistent with the results of two previous epidemiological studies .", "label": "", "metadata": {}, "score": "65.669655"}
{"text": "We found no evidence that current users of drospirenone as a group included a disproportionate number of short term or first time users ( who seem to carry a higher risk of venous thromboembolism 21 ) than did current users of levonorgestrel pills .", "label": "", "metadata": {}, "score": "65.86594"}
{"text": "There was significant heterogeneity across studies ( heterogeneity . )Among obese women , however , the pooled risk ratio indicated a sizable increased risk of esophageal adenocarcinoma compared to women of normal weight ( RR 2.04 ; 95 % confidence interval 1.18 to 3.55 ) .", "label": "", "metadata": {}, "score": "66.00508"}
{"text": "In these patients , the male : female ratio was 1 : 0.77 .Figure 1 shows the distribution of the age of these patients at disease onset .", "label": "", "metadata": {}, "score": "66.01859"}
{"text": "The median body mass index was 26.1 ( range 19.1 - 45.7 ) in cases and 23.3 ( 17.3 - 43.2 ) in controls .Body mass index was unknown for 34 women ( four cases ) ; for five of them ( all controls ) , smoking status was also unknown .", "label": "", "metadata": {}, "score": "66.24588"}
{"text": "Table 1 : Summary of results of meta - analysis of associations between obesity and cancer risk in 57 studies from 18 countries , 1985 - 2011 .", "label": "", "metadata": {}, "score": "66.25453"}
{"text": "We did not obtain copies of hospital discharge or outpatient clinic letters for all potential cases , but in the subset of women for whom we had such information all had confirmed venous thromboembolism and only four were considered non - idiopathic .", "label": "", "metadata": {}, "score": "66.332825"}
{"text": "Women were eligible for inclusion as potential cases if they were aged 15 - 44 years on the index date and were current users of a study oral contraceptive .", "label": "", "metadata": {}, "score": "67.0833"}
{"text": "The remaining 47 articles from Renehan et al 's review explored the association between obesity and cancers other than the thirteen of interest in this paper , and therefore were excluded .", "label": "", "metadata": {}, "score": "67.19708"}
{"text": "Studies were given an overall score out of 20 possible points and were then classified into three categories : strong , moderate , and weak .", "label": "", "metadata": {}, "score": "67.56291"}
{"text": "The peak was in the age range 61 - 70 years , and the disease - onset age in approximately one - third of the patients ( 33 % ) was 61 - 70 years .", "label": "", "metadata": {}, "score": "67.929855"}
{"text": "We took the date of the first new prescription for a study oral contraceptive after 1 May 2002 as the date of entry into the study cohort .", "label": "", "metadata": {}, "score": "67.95055"}
{"text": "Two industry funded cohort studies , which were done to meet post - marketing surveillance commitments , reported similar risks of venous thromboembolism in users of drospirenone and other oral contraceptives . 8 9 However , in one study , the reference group was not clearly defined and may have included women who took oral contraceptives associated with a higher risk of venous thromboembolism . 8 In the second study , the rates of venous thromboembolism in users of contraceptives containing levonorgestrel were reported to be similar not only to those in drospirenone users but also to those in users of other unspecified oral contraceptives .", "label": "", "metadata": {}, "score": "68.05386"}
{"text": "Four studies in men ( Figure 9(a ) ) and six in women ( Figure 9(b ) ) assessed the association between obesity and non - Hodgkin lymphoma .", "label": "", "metadata": {}, "score": "68.05613"}
{"text": "Women are at particularly high risk for as many as eight cancers , and the magnitude of the association is very high .Similarly among obese men , there is an increased risk for five cancers .", "label": "", "metadata": {}, "score": "68.15226"}
{"text": "Nine and ten studies , respectively , assessed the association between obesity and pancreatic cancer in men ( Figure 10(a ) ) and women ( Figure 10(b ) ) .", "label": "", "metadata": {}, "score": "68.15394"}
{"text": "As drospirenone first became available in the UK in April 2002 , we confined the study to the years after this date .We identified all women who had received at least one prescription for an oral contraceptive containing 30 \u00b5g oestrogen in combination with either drospirenone or levonorgestrel between 1 May 2002 and 30 September 2009 ( the study period ) .", "label": "", "metadata": {}, "score": "68.28164"}
{"text": "Clin Lab Haem 2005 ; 27 : 61 -6 .Jick SS , Hernandez RK .Risk of non - fatal venous thromboembolism in women using oral contraceptives containing drospirenone compared with women using oral contraceptives containing levonorgestrel : case - control study using United States claims data .", "label": "", "metadata": {}, "score": "68.34828"}
{"text": "This cohort had an estimated 73 853 woman years of use of the oral contraceptive containing 30 \u00b5g oestrogen and drospirenone and 482 229 woman years of use of preparations containing 30 \u00b5g oestrogen and levonorgestrel .", "label": "", "metadata": {}, "score": "68.35809"}
{"text": "Similarly , among obese women the pooled risk ratio demonstrated an increased risk of gallbladder cancer compared to women of normal weight ( RR 1.82 ; 95 % confidence interval 1.32 to 2.50 ) .", "label": "", "metadata": {}, "score": "68.595535"}
{"text": "Statistical Analysis 9 for Change From Baseline in Health - Related Quality of Life ( QOL ) as Measured by the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire ( EORTC QLQ - C30 ) Instrument at Week 12 .", "label": "", "metadata": {}, "score": "68.63513"}
{"text": "The question Renehan et al .answered was broader in that they were interested in assessing across the spectrum of BMI from normal to obese , the relationship between BMI and cancer risk .", "label": "", "metadata": {}, "score": "68.82302"}
{"text": "When the results of this meta - analysis are compared to those of Renehan et al .[ 6 ] , who reviewed similar but earlier literature on obesity and cancer , a number of important similarities and differences are observed .", "label": "", "metadata": {}, "score": "68.8362"}
{"text": "All four studies included some non - idiopathic cases ( women with other known risk factors for venous thromboembolism ) .The presence of risk factors for venous thromboembolism not only affects the probability of the woman developing the condition but also influences decisions about prescribing of oral contraceptives .", "label": "", "metadata": {}, "score": "68.88788"}
{"text": "Education level ranged from primary school to postsecondary .Among the cohort studies participants were followed up between 6 and 39 years .Association between Obesity and Cancer Incidence .", "label": "", "metadata": {}, "score": "69.16135"}
{"text": "Statistical Analysis 14 for Change From Baseline in Health - Related Quality of Life ( QOL ) as Measured by the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire ( EORTC QLQ - C30 ) Instrument at Week 12 .", "label": "", "metadata": {}, "score": "69.28462"}
{"text": "Change From Baseline in Health - Related Quality of Life ( QOL ) as Measured by the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire ( EORTC QLQ - C30 ) Instrument at Week 12 .", "label": "", "metadata": {}, "score": "69.33298"}
{"text": "Statistical Analysis 13 for Change From Baseline in Health - Related Quality of Life ( QOL ) as Measured by the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire ( EORTC QLQ - C30 ) Instrument at Week 12 .", "label": "", "metadata": {}, "score": "69.400894"}
{"text": "Statistical Analysis 12 for Change From Baseline in Health - Related Quality of Life ( QOL ) as Measured by the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire ( EORTC QLQ - C30 ) Instrument at Week 12 .", "label": "", "metadata": {}, "score": "69.450516"}
{"text": "We synthesized 20 years of cumulative evidence on racial / ethnic disparities in analgesic treatment for pain in the United States .Evidence was examined for the 1 ) magnitude of association between race / ethnicity and analgesic treatment ; 2 ) subgroups at an increased risk ; and 3 ) the effect of moderators ( pain type , setting , study quality , and data collection period ) on this association .", "label": "", "metadata": {}, "score": "69.482346"}
{"text": "Statistical Analysis 11 for Change From Baseline in Health - Related Quality of Life ( QOL ) as Measured by the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire ( EORTC QLQ - C30 ) Instrument at Week 12 .", "label": "", "metadata": {}, "score": "69.54266"}
{"text": "We did a case - control study nested in a cohort of users of oral contraceptives containing 30 \u00b5g oestrogen in combination with either drospirenone or levonorgestrel .", "label": "", "metadata": {}, "score": "69.5549"}
{"text": "Statistical Analysis 8 for Change From Baseline in Health - Related Quality of Life ( QOL ) as Measured by the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire ( EORTC QLQ - C30 ) Instrument at Week 12 .", "label": "", "metadata": {}, "score": "69.77928"}
{"text": "Those obtaining a score of 11 - 15 points received a rating of moderate , and those obtaining a score of 10 or less were rated as weak .", "label": "", "metadata": {}, "score": "69.78975"}
{"text": "Statistical Analysis 44 for Change From Baseline in Health - Related Quality of Life ( QOL ) as Measured by the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire ( EORTC QLQ - C30 ) Instrument at Week 12 .", "label": "", "metadata": {}, "score": "69.86743"}
{"text": "Statistical Analysis 10 for Change From Baseline in Health - Related Quality of Life ( QOL ) as Measured by the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire ( EORTC QLQ - C30 ) Instrument at Week 12 .", "label": "", "metadata": {}, "score": "70.008316"}
{"text": "We considered consecutive prescriptions for a study oral contraceptive to be part of the same episode of use if the elapsed time between the end date of any one prescription and the issue of the next did not exceed 100 days .", "label": "", "metadata": {}, "score": "70.15479"}
{"text": "Statistical Analysis 18 for Change From Baseline in Health - Related Quality of Life ( QOL ) as Measured by the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire ( EORTC QLQ - C30 ) Instrument at Week 12 .", "label": "", "metadata": {}, "score": "70.28415"}
{"text": "Statistical Analysis 19 for Change From Baseline in Health - Related Quality of Life ( QOL ) as Measured by the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire ( EORTC QLQ - C30 ) Instrument at Week 12 .", "label": "", "metadata": {}, "score": "70.31372"}
{"text": "Statistical Analysis 15 for Change From Baseline in Health - Related Quality of Life ( QOL ) as Measured by the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire ( EORTC QLQ - C30 ) Instrument at Week 12 .", "label": "", "metadata": {}, "score": "70.356995"}
{"text": "Our study quantifies the magnitude of analgesic treatment disparities in subgroups of minorities .The size of the difference was sufficiently large to raise not only normative but quality and safety concerns .", "label": "", "metadata": {}, "score": "70.42348"}
{"text": "When we excluded these women , the adjusted ( for body mass index ) matched odds ratio was 3.2 ( 1.1 to 8.7 ) .Adjustment for switching ( and body mass index ) , rather than excluding these women , produced similar results ; the odds ratio was 3.6 ( 1.4 to 9.0 ) .", "label": "", "metadata": {}, "score": "70.43144"}
{"text": "The number of patients with IgG4-related lymphadenopathy without autoimmune pancreatitis who visited hospitals was approximately 203 ( 95 % confidence interval ; range 187 - 240 ) ( Figure 6 ) .", "label": "", "metadata": {}, "score": "70.557724"}
{"text": "Of the remaining 98 studies one was assessed as being of strong methodological quality , 56 were rated as moderate and 41 as weak .Data was extracted on the 57 strong and moderate studies .", "label": "", "metadata": {}, "score": "70.63489"}
{"text": "Statistical Analysis 43 for Change From Baseline in Health - Related Quality of Life ( QOL ) as Measured by the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire ( EORTC QLQ - C30 ) Instrument at Week 12 .", "label": "", "metadata": {}, "score": "70.68439"}
{"text": "There was significant heterogeneity across studies ( heterogeneity . )Similarly among obese women the pooled risk ratio illustrated no increased risk of rectal cancer compared to women of normal weight ( RR 1.03 ; 95 % confidence interval 0.74 to 1.44 ) .", "label": "", "metadata": {}, "score": "70.73767"}
{"text": "Statistical Analysis 21 for Change From Baseline in Health - Related Quality of Life ( QOL ) as Measured by the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire ( EORTC QLQ - C30 ) Instrument at Week 12 .", "label": "", "metadata": {}, "score": "70.79201"}
{"text": "Statistical Analysis 22 for Change From Baseline in Health - Related Quality of Life ( QOL ) as Measured by the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire ( EORTC QLQ - C30 ) Instrument at Week 12 .", "label": "", "metadata": {}, "score": "70.86359"}
{"text": "Statistical Analysis 20 for Change From Baseline in Health - Related Quality of Life ( QOL ) as Measured by the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire ( EORTC QLQ - C30 ) Instrument at Week 12 .", "label": "", "metadata": {}, "score": "70.88106"}
{"text": "Statistical Analysis 5 for Change From Baseline in Health - Related Quality of Life ( QOL ) as Measured by the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire ( EORTC QLQ - C30 ) Instrument at Week 12 .", "label": "", "metadata": {}, "score": "70.91384"}
{"text": "Statistical Analysis 45 for Change From Baseline in Health - Related Quality of Life ( QOL ) as Measured by the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire ( EORTC QLQ - C30 ) Instrument at Week 12 .", "label": "", "metadata": {}, "score": "70.930855"}
{"text": "It is estimated that globally , every year , three to four million cases of cancer could be prevented by eating healthier and being more physically active [ 2 ] .", "label": "", "metadata": {}, "score": "70.98869"}
{"text": "Statistical Analysis 32 for Change From Baseline in Health - Related Quality of Life ( QOL ) as Measured by the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire ( EORTC QLQ - C30 ) Instrument at Week 12 .", "label": "", "metadata": {}, "score": "71.04509"}
{"text": "We took current use as the relevant exposure period , because the risk of venous thromboembolism is increased while women are taking oral contraceptives and then returns to normal baseline levels once such use is discontinued .", "label": "", "metadata": {}, "score": "71.04794"}
{"text": "What this study adds .Current use of the drospirenone oral contraceptive was associated with a threefold increase in idiopathic non - fatal venous thromboembolism compared with current use of levonorgestrel pills , although the overall risk was still low .", "label": "", "metadata": {}, "score": "71.08953"}
{"text": "Statistical Analysis 16 for Change From Baseline in Health - Related Quality of Life ( QOL ) as Measured by the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire ( EORTC QLQ - C30 ) Instrument at Week 12 .", "label": "", "metadata": {}, "score": "71.15603"}
{"text": "Statistical Analysis 39 for Change From Baseline in Health - Related Quality of Life ( QOL ) as Measured by the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire ( EORTC QLQ - C30 ) Instrument at Week 12 .", "label": "", "metadata": {}, "score": "71.18625"}
{"text": "We also examined the risks of pulmonary embolism and deep vein thrombosis separately ; the matched odds ratio for pulmonary embolism ( adjusted for body mass index ) was 2.1 ( 0.8 to 5.6 ) .", "label": "", "metadata": {}, "score": "71.32633"}
{"text": "One hundred and one studies were assessed for methodological quality .It was identified during quality assessment that three studies ( judged to be of moderate quality ) reported data in a way that was inconsistent with the other studies , therefore could not be aggregated with other studies .", "label": "", "metadata": {}, "score": "71.33094"}
{"text": "Furthermore , cancer and cardiovascular diseases are the leading causes of mortality and morbidity worldwide [ 2 ] , with cancer expected to result in 75,000 deaths per year in Canada [ 3 ] and 571,950 in the US [ 4 ] .", "label": "", "metadata": {}, "score": "71.49457"}
{"text": "Statistical Analysis 7 for Change From Baseline in Health - Related Quality of Life ( QOL ) as Measured by the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire ( EORTC QLQ - C30 ) Instrument at Week 12 .", "label": "", "metadata": {}, "score": "71.49727"}
{"text": "From the computer records , we identified 65 potentially eligible cases of venous thromboembolism .We sent for hospital discharge or outpatient clinic letters for 42 of these women , and we received information for 31 .", "label": "", "metadata": {}, "score": "71.4974"}
{"text": "Canadian research estimates the economic burden of obesity as $ 2.1 billion in both direct and indirect costs [ 12 ] .Data from that same study suggests that a 10 % decrease in inactivity would result in health savings of $ 150 million per annum [ 13 ] .", "label": "", "metadata": {}, "score": "71.53162"}
{"text": "Statistical Analysis 6 for Change From Baseline in Health - Related Quality of Life ( QOL ) as Measured by the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire ( EORTC QLQ - C30 ) Instrument at Week 12 .", "label": "", "metadata": {}, "score": "71.559685"}
{"text": "Statistical Analysis 42 for Change From Baseline in Health - Related Quality of Life ( QOL ) as Measured by the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire ( EORTC QLQ - C30 ) Instrument at Week 12 .", "label": "", "metadata": {}, "score": "71.57475"}
{"text": "The Kappa score for agreement between reviewers on relevance assessment was 0.835 , indicating high agreement .Reasons studies found to be not relevant were data not reported on the 13 cancers , and/or the association between obesity and cancer in adults aged 18 years and older was not the focus of the study .", "label": "", "metadata": {}, "score": "71.80051"}
{"text": "Statistical Analysis 17 for Change From Baseline in Health - Related Quality of Life ( QOL ) as Measured by the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire ( EORTC QLQ - C30 ) Instrument at Week 12 .", "label": "", "metadata": {}, "score": "72.03461"}
{"text": "Statistical Analysis 41 for Change From Baseline in Health - Related Quality of Life ( QOL ) as Measured by the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire ( EORTC QLQ - C30 ) Instrument at Week 12 .", "label": "", "metadata": {}, "score": "72.09448"}
{"text": "These odds ratios from the imputed missing data analysis were slightly higher than those obtained in the complete case analysis ( the analysis that excluded cases and controls with missing body mass index and the controls of the excluded cases ) .", "label": "", "metadata": {}, "score": "72.25545"}
{"text": "Statistical Analysis 40 for Change From Baseline in Health - Related Quality of Life ( QOL ) as Measured by the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire ( EORTC QLQ - C30 ) Instrument at Week 12 .", "label": "", "metadata": {}, "score": "72.37363"}
{"text": "Statistical Analysis 27 for Change From Baseline in Health - Related Quality of Life ( QOL ) as Measured by the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire ( EORTC QLQ - C30 ) Instrument at Week 12 .", "label": "", "metadata": {}, "score": "72.48717"}
{"text": "The number of newly contracted patients in one year was 1,120 patients ( 95 % confidence interval ; range 1,000 - 1,240 ) .Japanese vital statics of the Ministry of Health , Labor and Welfare for 2007 showed the total population to be 127,771,000 people ( adult population , 104,197,000 ) .", "label": "", "metadata": {}, "score": "72.57124"}
{"text": "Statistical Analysis 38 for Change From Baseline in Health - Related Quality of Life ( QOL ) as Measured by the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire ( EORTC QLQ - C30 ) Instrument at Week 12 .", "label": "", "metadata": {}, "score": "72.60218"}
{"text": "Statistical Analysis 31 for Change From Baseline in Health - Related Quality of Life ( QOL ) as Measured by the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire ( EORTC QLQ - C30 ) Instrument at Week 12 .", "label": "", "metadata": {}, "score": "72.60361"}
{"text": "Further work is needed to identify the optimal role of ED settings in providing screening , education , and treatment referral for individuals using prescription pain medications non - medically .", "label": "", "metadata": {}, "score": "72.61636"}
{"text": "The main limitation of this study was the relatively small number of cases , which inevitably limited the precision of our estimates of relative risk in the subanalyses , as shown by the wide 95 % confidence intervals .", "label": "", "metadata": {}, "score": "72.65494"}
{"text": "Statistical Analysis 28 for Change From Baseline in Health - Related Quality of Life ( QOL ) as Measured by the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire ( EORTC QLQ - C30 ) Instrument at Week 12 .", "label": "", "metadata": {}, "score": "72.674255"}
{"text": "Statistical Analysis 23 for Change From Baseline in Health - Related Quality of Life ( QOL ) as Measured by the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire ( EORTC QLQ - C30 ) Instrument at Week 12 .", "label": "", "metadata": {}, "score": "72.82893"}
{"text": "Objective To examine the risk of non - fatal idiopathic venous thromboembolism in current users of a combined oral contraceptive containing drospirenone , relative to current users of preparations containing levonorgestrel .", "label": "", "metadata": {}, "score": "72.85484"}
{"text": "Two researchers , blinded to exposure status , independently reviewed the computerised medical records of the potential cases to identify women who had temporary risk factors for venous thromboembolism shortly before the index date .", "label": "", "metadata": {}, "score": "72.98143"}
{"text": "Statistical Analysis 30 for Change From Baseline in Health - Related Quality of Life ( QOL ) as Measured by the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire ( EORTC QLQ - C30 ) Instrument at Week 12 .", "label": "", "metadata": {}, "score": "73.05517"}
{"text": "Statistical Analysis 29 for Change From Baseline in Health - Related Quality of Life ( QOL ) as Measured by the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire ( EORTC QLQ - C30 ) Instrument at Week 12 .", "label": "", "metadata": {}, "score": "73.25115"}
{"text": "Statistical Analysis 3 for Change From Baseline in Health - Related Quality of Life ( QOL ) as Measured by the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire ( EORTC QLQ - C30 ) Instrument at Week 12 .", "label": "", "metadata": {}, "score": "73.25856"}
{"text": "Statistical Analysis 24 for Change From Baseline in Health - Related Quality of Life ( QOL ) as Measured by the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire ( EORTC QLQ - C30 ) Instrument at Week 12 .", "label": "", "metadata": {}, "score": "73.37526"}
{"text": "Conclusions and policy implications .This study adds to emerging evidence that use of the oral contraceptive containing drospirenone is associated with a higher risk of venous thromboembolism than are preparations containing levonorgestrel .", "label": "", "metadata": {}, "score": "73.475784"}
{"text": "Elsewhere the cost of obesity to the health care system has been found to represent 2.3 % of annual hospital care costs [ 11 ] .", "label": "", "metadata": {}, "score": "73.501366"}
{"text": "Finally , it may be that studies published since the Renehan et al . meta - analysis , report higher relative risks than had been reported previously .", "label": "", "metadata": {}, "score": "73.58519"}
{"text": "Statistical Analysis 4 for Change From Baseline in Health - Related Quality of Life ( QOL ) as Measured by the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire ( EORTC QLQ - C30 ) Instrument at Week 12 .", "label": "", "metadata": {}, "score": "73.70339"}
{"text": "Statistical Analysis 26 for Change From Baseline in Health - Related Quality of Life ( QOL ) as Measured by the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire ( EORTC QLQ - C30 ) Instrument at Week 12 .", "label": "", "metadata": {}, "score": "73.73497"}
{"text": "Statistical Analysis 37 for Change From Baseline in Health - Related Quality of Life ( QOL ) as Measured by the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire ( EORTC QLQ - C30 ) Instrument at Week 12 .", "label": "", "metadata": {}, "score": "73.73898"}
{"text": "Statistical Analysis 36 for Change From Baseline in Health - Related Quality of Life ( QOL ) as Measured by the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire ( EORTC QLQ - C30 ) Instrument at Week 12 .", "label": "", "metadata": {}, "score": "73.780334"}
{"text": "Statistical Analysis 34 for Change From Baseline in Health - Related Quality of Life ( QOL ) as Measured by the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire ( EORTC QLQ - C30 ) Instrument at Week 12 .", "label": "", "metadata": {}, "score": "73.79065"}
{"text": "Strengths and limitations of study .The study had several strengths .Thirdly , for both cases and controls , information about the medical history and prescription of oral contraceptives and other drugs came from medical records and hence was not subject to recall bias .", "label": "", "metadata": {}, "score": "73.924576"}
{"text": "Studies of weak methodological quality rated poorly on these criteria as well as research design .A summary of the quality assessment of the 57 studies included in the meta - analysis is presented in Figure 1 .", "label": "", "metadata": {}, "score": "74.2303"}
{"text": "As can be seen from Tables 2 and 3 , the three proposed confidence intervals have estimated coverage probabilities close to the nominal confidence level in all cases .", "label": "", "metadata": {}, "score": "74.36044"}
{"text": "Thus , our results seem very unlikely to be explained by any selective prescribing of the newer product to women at higher risk of venous thromboembolism .", "label": "", "metadata": {}, "score": "74.439"}
{"text": "Statistical Analysis 25 for Change From Baseline in Health - Related Quality of Life ( QOL ) as Measured by the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire ( EORTC QLQ - C30 ) Instrument at Week 12 .", "label": "", "metadata": {}, "score": "74.51098"}
{"text": "Table 2 : Population - attributable risk percent in Canada for obesity and cancer .Among women PAR% ranged from a low of 4.2 % to a high of 19.4 % .", "label": "", "metadata": {}, "score": "74.544235"}
{"text": "The results of studies of weak methodological quality are less trustworthy .The exclusion of these studies likely contributed to the higher pooled risk ratios observed in this meta - analysis in comparison to Renehan et al .", "label": "", "metadata": {}, "score": "74.56092"}
{"text": "The confidence intervals of the aforementioned authors have not been used for estimating the population coefficient of variation for the normal distribution with a known population mean .", "label": "", "metadata": {}, "score": "74.65695"}
{"text": "Statistical Analysis 33 for Change From Baseline in Health - Related Quality of Life ( QOL ) as Measured by the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire ( EORTC QLQ - C30 ) Instrument at Week 12 .", "label": "", "metadata": {}, "score": "74.69695"}
{"text": "Specifically the association between obesity and thirteen cancers shown previously [ 6 ] to be significantly associated with obesity is the focus of this meta - analysis .", "label": "", "metadata": {}, "score": "74.700745"}
{"text": "Then we will show how sample data can be used to construct a confidence interval .Assume that the weights of 10-year old children are normally distributed with a mean of 90 and a standard deviation of 36 .", "label": "", "metadata": {}, "score": "74.78915"}
{"text": "A slightly smaller proportion of cases than controls were current smokers .Three cases and nine controls had a history of varicose veins ; one control had a history of superficial venous thrombosis .", "label": "", "metadata": {}, "score": "74.96562"}
{"text": "Statistical Analysis 35 for Change From Baseline in Health - Related Quality of Life ( QOL ) as Measured by the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire ( EORTC QLQ - C30 ) Instrument at Week 12 .", "label": "", "metadata": {}, "score": "75.13342"}
{"text": "View at Google Scholar .M. Smithson , \" Correct confidence intervals for various regression effect sizes and parameters : the importance of noncentral distributions in computing intervals , \" Educational and Psychological Measurement , vol .", "label": "", "metadata": {}, "score": "75.458786"}
{"text": "Seeger JD , Loughlin J , Eng PM , Clifford CR , Cutone J , Walker AM .Risk of thromboembolism in women taking ethinylestradiol / drospirenone and other oral contraceptives .", "label": "", "metadata": {}, "score": "75.464"}
{"text": "In 2002 a series of case reports raised concerns about the risk of venous thromboembolism in users of a recently marketed oral contraceptive containing 30 \u00b5g oestrogen and a new progestogen , drospirenone . 1 These reports emerged in the wake of earlier findings that oral contraceptives containing the newer progestogens desogestrel and gestodene ( \" third generation \" pills ) , and cyproterone acetate , carried higher risks of venous thromboembolism than did pills containing an older progestogen , levonorgestrel .", "label": "", "metadata": {}, "score": "75.47988"}
{"text": "After adjustment for body mass index , the odds ratio for validated cases was 4.0 ( 0.9 to 16.5 ) and that for unvalidated cases was 3.0 ( 1.0 to 8.5 ) ; the P value for the interaction was 0.8 .", "label": "", "metadata": {}, "score": "75.51837"}
{"text": "A confidence interval provides much more information about the population characteristic of interest than does a point estimate ( e.g. , Smithson [ 9 ] , Thompson [ 10 ] , and Steiger [ 11 ] ) .", "label": "", "metadata": {}, "score": "75.93858"}
{"text": "12 We therefore did a nested case - control study to estimate the risk of non - fatal idiopathic venous thromboembolism associated with current use of the oral contraceptive containing drospirenone relative to current use of preparations containing levonorgestrel .", "label": "", "metadata": {}, "score": "76.00983"}
{"text": "This result confirms that the three confidence intervals proposed in this paper are more efficient than the existing confidence intervals in terms of length of interval .", "label": "", "metadata": {}, "score": "76.28981"}
{"text": "Jick H , Kaye JA , Vasilakis - Scaramozza C , Jick SS .Risk of venous thromboembolism among users of third generation oral contraceptives compared with users of oral contraceptives with levonorgestrel before and after 1995 : cohort and case - control analysis .", "label": "", "metadata": {}, "score": "76.29901"}
{"text": "Statistical Analysis 2 for Change From Baseline in Health - Related Quality of Life ( QOL ) as Measured by the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire ( EORTC QLQ - C30 ) Instrument at Week 12 .", "label": "", "metadata": {}, "score": "76.43962"}
{"text": "Dinger JC , Heinemann LAJ , Kuhl - Habich D. The safety of a drospirenone - containing oral contraceptive : final results from the European Active Surveillance Study on oral contraceptives based on 142,475 women - years of observation .", "label": "", "metadata": {}, "score": "76.480194"}
{"text": ", where , P is the population prevalence of obesity , and RR is the pooled risk ratio [ 12 ] .The most current obesity rates for men and women available in Canada [ 9 ] were used to represent population prevalence .", "label": "", "metadata": {}, "score": "76.582825"}
{"text": "Similar differences existed for obese women with the greatest differences in the pooled risk ratios and 95 % confidence intervals being for three cancers : endometrial , renal , and gallbladder .", "label": "", "metadata": {}, "score": "76.671684"}
{"text": "For endometrial cancer we reported a risk ratio of 1.85 ( 1.30 , 2.65 ) , while Renehan et al . reported 1.59 ( 1.5 , 1.68 ) .", "label": "", "metadata": {}, "score": "76.7801"}
{"text": "Relevant papers from a previously conducted review were included in this paper .In addition , database searches of Medline and Embase identified studies published from the date of the search conducted for the previous review ( January , 2007 ) until May , 2011 .", "label": "", "metadata": {}, "score": "77.042816"}
{"text": "Any disagreement between the reviewers was discussed and a consensus was reached .Controls .For each eligible case , we randomly selected from the study cohort up to four controls matched by year of birth ( within two years ) , number of years of recorded data , and general practice .", "label": "", "metadata": {}, "score": "77.30878"}
{"text": "Discussion .The results of this meta - analysis demonstrate a significant association between obesity and some of the 13 cancers for men and many of the 13 cancers for women .", "label": "", "metadata": {}, "score": "77.33873"}
{"text": "Controls were subject to the same exclusion criteria as cases .Statistical analysis .We used conditional logistic regression to compute odds ratios and 95 % confidence intervals in the case - control analyses .", "label": "", "metadata": {}, "score": "77.35088"}
{"text": "A total of 98 studies conducted in 18 countries from 1985 to 2011 were included .Data extraction was completed on the 57 studies judged to be of strong and moderate methodological quality .", "label": "", "metadata": {}, "score": "77.38222"}
{"text": "90 - 115 , 2004 .View at Google Scholar \u00b7 View at Scopus .P. T. Katzmarzyk , N. Gledhill , and R. J. Shephard , \" The economic burden of physical inactivity in Canada , \" Canadian Medical Association Journal , vol .", "label": "", "metadata": {}, "score": "77.39845"}
{"text": "Adjustment for body mass index gave an even higher odds ratio with a very wide confidence interval , indicating that the estimate was unreliable in this small subgroup .", "label": "", "metadata": {}, "score": "77.41373"}
{"text": "4 , pp .605 - 632 , 2001 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .B. Thompson , \" What future quantitative social science research could look like : confidence intervals for effect sizes , \" Educational Researcher , vol .", "label": "", "metadata": {}, "score": "77.72506"}
{"text": "There was no significant heterogeneity across the two studies ( heterogeneity .Figure 8 : ( a ) Obesity and multiple myeloma in men .( b ) Obesity and multiple myeloma in women .", "label": "", "metadata": {}, "score": "77.93625"}
{"text": "Relevance assessment , quality assessment , and data extraction for each study were conducted by two reviewers independently .Meta - analysis was performed for men and women separately using DerSimonian and Laird 's random effects model .", "label": "", "metadata": {}, "score": "78.33084"}
{"text": "There was only one cancer where Renehan et al . reported a larger risk ratio than we did , which was for non - Hodgkin lymphoma .", "label": "", "metadata": {}, "score": "78.66113"}
{"text": "The search strategy employed by Renehan et al .identified studies published between 1985 and 2007 , indexed in Medline and Embase .Three additional studies , noted by Renehan et al . , but published after their search was conducted , and therefore not included in their review , were also retrieved .", "label": "", "metadata": {}, "score": "78.70409"}
{"text": "Significant events and approaches for the overall study following participant enrollment , but prior to group assignment .Of the 1783 participants who enrolled and were screened for study participation , a total of 676 subjects were randomized .", "label": "", "metadata": {}, "score": "78.92296"}
{"text": "It was assumed that 2.773 times the number of presumptive patients in these 250 hospitals would be the number of estimated patients for the whole country .", "label": "", "metadata": {}, "score": "79.01828"}
{"text": "All potentially relevant studies were retrieved in PDF version .Finally , the reference lists of relevant studies were screened to identify additional potentially relevant studies , as well as the reference lists of published systematic reviews or meta - analyses on this topic .", "label": "", "metadata": {}, "score": "79.03522"}
{"text": "A significant association was not observed among obese men for esophageal adenocarcinoma , leukemia , multiple myeloma , non - Hodgkin lymphoma , rectal , and thyroid cancer .", "label": "", "metadata": {}, "score": "79.038284"}
{"text": "134 , pp .6691 - 6704 , 2012 .View at Google Scholar .M. Gulhar , B. M. G. Kibria , A. N. Albatineh , and N. U. Ahmed , \" A comparison of some confidence intervals for estimating the population coefficient of variation : a simulation study , \" SORT , vol .", "label": "", "metadata": {}, "score": "79.15378"}
{"text": "Death Rate ( 95 % Confidence Interval ) - The death rate is based upon 100,000 people and is for 5 year(s ) .Rates are age - adjusted by 5-year age groups to the 2000 U.S. standard million population ( the Healthy People 2020 goals are based on rates adjusted using different methods but the differences should be minimal ) .", "label": "", "metadata": {}, "score": "79.156555"}
{"text": "Rectal Cancer .There were 11 studies for men ( Figure 12(a ) ) and nine for women ( Figure 12(b ) ) that assessed the association between obesity and rectal cancer .", "label": "", "metadata": {}, "score": "79.157745"}
{"text": "Figure 1 : Sex and age of onset of IgG4-related disease .The male : female ratio was 1 : 0.77 , and the average of age of disease onset was 58.8 years .", "label": "", "metadata": {}, "score": "79.24742"}
{"text": "The number of patients with IgG4-related renal disease without autoimmune pancreatitis , who visited hospitals was approximately 57 ( 95 % confidence interval ; range 47 - 66 ) ( Figure 4 ) .", "label": "", "metadata": {}, "score": "79.59718"}
{"text": "For example , at the upper limit of the confidence interval the risk ratio is as high as 3.55 for esophageal adenocarcinoma , 2.65 for endometrial , and 2.50 for gallbladder cancer .", "label": "", "metadata": {}, "score": "79.76452"}
{"text": "For example for colon cancer PAR% is as low as 9.9 % but at the upper limit of the confidence interval PAR% is 13.1 % .", "label": "", "metadata": {}, "score": "79.80323"}
{"text": "From these selections , 2972 departments were nominated .A questionnaire was sent to the selected departments along with the diagnostic criteria for AIP , and respondents were asked to provide the number and sex of AIP patients who had visited the hospital in 2007 .", "label": "", "metadata": {}, "score": "79.87841"}
{"text": "Since 95 % of the distribution is within 23.52 of 90 , the probability that the mean from any given sample will be within 23.52 of 90 is 0.95 .", "label": "", "metadata": {}, "score": "79.94231"}
{"text": "RESULTS : Both groups showed marked improvement during the follow - up .The mean improvement in the Kujala score was 12.9 ( 95 % confidence interval ( CI ) 8.2 - 17.6 ) in the arthroscopy group and 11.4 ( 95 % CI 6.9 - 15.8 ) in the control group .", "label": "", "metadata": {}, "score": "79.95524"}
{"text": "RESULTS : Both groups showed marked improvement during the follow - up .The mean improvement in the Kujala score was 12.9 ( 95 % confidence interval ( CI ) 8.2 - 17.6 ) in the arthroscopy group and 11.4 ( 95 % CI 6.9 - 15.8 ) in the control group .", "label": "", "metadata": {}, "score": "79.95524"}
{"text": "[ 1 ] .Additional details about the analysis , such as null hypothesis and power calculation : .Global quality of life change from baseline .", "label": "", "metadata": {}, "score": "80.65135"}
{"text": "[ 1 ] .Additional details about the analysis , such as null hypothesis and power calculation : .Global quality of life change from baseline .", "label": "", "metadata": {}, "score": "80.65135"}
{"text": "Figure 12 : ( a ) Obesity and rectal cancer in men .( b ) Obesity and rectal cancer in women .Renal Cancer .", "label": "", "metadata": {}, "score": "81.01329"}
{"text": "\" [ Show abstract ] [ Hide abstract ] ABSTRACT : Background : There are no population - based studies of emergency department ( ED ) utilization by individuals using prescription pain medications non - medically .", "label": "", "metadata": {}, "score": "81.070114"}
{"text": "Tchaikovski SN , van Vliet HAAM , Thomassen MCLGD , Bertina RM , Rosendaal FR , Morten Sandset P , et al .Effect of oral contraceptives on thrombin generation measured via calibrated automated thrombography .", "label": "", "metadata": {}, "score": "81.1826"}
{"text": "Analyses were performed and reported separately by sex .In all instances reference body mass index ( BMI ) was 18.5 - 24.99 which was compared to the BMI category of 30 or more .", "label": "", "metadata": {}, "score": "81.22302"}
{"text": "Additionally , when the sample sizes increase , the lengths become shorter ( i.e. , for 95 % shortest - length confidence interval , .An Empirical Application .", "label": "", "metadata": {}, "score": "81.374245"}
{"text": "A Monte Carlo simulation study was conducted to compare the performance of the proposed confidence intervals with the existing confidence intervals .Simulation results have shown that all three proposed confidence intervals perform well in terms of coverage probability and expected length .", "label": "", "metadata": {}, "score": "81.480194"}
{"text": "The Healthy People 2020 goals are based on rates adjusted using different methods but the differences should be minimal .Population counts for denominators are based on Census populations as modified by NCI .", "label": "", "metadata": {}, "score": "81.51267"}
{"text": "Background .Cancer and cardiovascular diseases are the leading causes of mortality and morbidity worldwide .The purpose of this meta - analysis is to synthesize the evidence evaluating the association between obesity and 13 cancers shown previously to be significantly associated with obesity .", "label": "", "metadata": {}, "score": "81.55372"}
{"text": "We used chained equations to impute missing values of body mass index and smoking status 16 17 18 ; we used 100 imputations to obtain stability to one decimal place .", "label": "", "metadata": {}, "score": "81.563965"}
{"text": "Methods : We conducted a retrospective analysis of a nationally representative sample of the non - institutionalized , civilian U.S. population in the National Survey on Drug Use and Health , 2008 - 2013 .", "label": "", "metadata": {}, "score": "81.74559"}
{"text": "[ 1 ] .Additional details about the analysis , such as null hypothesis and power calculation : .Emotional change from baseline .[ 2 ] .", "label": "", "metadata": {}, "score": "81.75523"}
{"text": "[ 1 ] .Additional details about the analysis , such as null hypothesis and power calculation : .Emotional change from baseline .[ 2 ] .", "label": "", "metadata": {}, "score": "81.75523"}
{"text": "[ 1 ] .Additional details about the analysis , such as null hypothesis and power calculation : .Emotional change from baseline .[ 2 ] .", "label": "", "metadata": {}, "score": "81.75523"}
{"text": "[ 1 ] .Additional details about the analysis , such as null hypothesis and power calculation : .Role change , change from baseline .", "label": "", "metadata": {}, "score": "81.815414"}
{"text": "[ 1 ] .Additional details about the analysis , such as null hypothesis and power calculation : .Role change , change from baseline .", "label": "", "metadata": {}, "score": "81.815414"}
{"text": "There was significant heterogeneity across studies ( heterogeneity . )Among obese women the pooled risk ratio also showed an increased risk of pancreatic cancer compared to women of normal weight ( RR 1.34 ; 95 % confidence interval 1.22 to 1.46 ) .", "label": "", "metadata": {}, "score": "81.89597"}
{"text": "The number of patients with IgG4-related lymphadenopathy without autoimmune pancreatitis , who visited hospitals in Japan in 2009 , was approximately 203 ( 95 % confidence interval ; range 187 - 240 ) .", "label": "", "metadata": {}, "score": "81.91621"}
{"text": "unknown .[ 1 ] .Duration of melanoma is the number of years from date of initial diagnosis to the date of randomization .The randomization of 1 participant in the ipilumumab monotherapy cohort was prior to the initial diagnostic date .", "label": "", "metadata": {}, "score": "81.95568"}
{"text": "When the 95 % confidence intervals for PAR% for women are considered the results are also noteworthy .For example , at the upper limit of the confidence interval , PAR% was as high as 37.2 % for esophageal adenocarcinoma , 27.7 % for endometrial cancer , and 25.8 % for gallbladder cancer .", "label": "", "metadata": {}, "score": "82.09539"}
{"text": "[ 1 ] .Additional details about the analysis , such as null hypothesis and power calculation : .Sleep disturbance change from baseline .[ 2 ] .", "label": "", "metadata": {}, "score": "82.141464"}
{"text": "[ 1 ] .Additional details about the analysis , such as null hypothesis and power calculation : .Sleep disturbance change from baseline .[ 2 ] .", "label": "", "metadata": {}, "score": "82.141464"}
{"text": "[ 1 ] .Additional details about the analysis , such as null hypothesis and power calculation : .Sleep Disturbance change from baseline .[ 2 ] .", "label": "", "metadata": {}, "score": "82.141464"}
{"text": "Additional details about the analysis , such as null hypothesis and power calculation : .Pain change from baseline .[ 2 ] .Other relevant method information , such as adjustments or degrees of freedom : .", "label": "", "metadata": {}, "score": "82.240875"}
{"text": "Additional details about the analysis , such as null hypothesis and power calculation : .Pain change from baseline .[ 2 ] .Other relevant method information , such as adjustments or degrees of freedom : .", "label": "", "metadata": {}, "score": "82.240875"}
{"text": "Figure 9 : ( a ) Obesity and non - Hodgkin lymphoma in men .( b ) Obesity and non - Hodgkin lymphoma in women .", "label": "", "metadata": {}, "score": "82.356384"}
{"text": "Likely the most significant factor contributing to the differences in the results of the two meta - analyses are the different approaches to the statistical methods used to aggregate the data across studies .", "label": "", "metadata": {}, "score": "82.64003"}
{"text": "S. Borg , U. Persson , K. Odegaard , G. Berglund , J.-A. Nilsson , and P. M. Nilsson , \" Obesity , survival , and hospital costs \u2014 findings from a screening project in Sweden , \" Value in Health , vol . 8 , no .", "label": "", "metadata": {}, "score": "82.746475"}
{"text": "Conclusions These findings contribute to emerging evidence that the combined oral contraceptive containing drospirenone carries a higher risk of venous thromboembolism than do formulations containing levonorgestrel .", "label": "", "metadata": {}, "score": "82.808044"}
{"text": "Additional details about the analysis , such as null hypothesis and power calculation : .Dyspnea change from baseline .[ 2 ] .Other relevant method information , such as adjustments or degrees of freedom : .", "label": "", "metadata": {}, "score": "82.88576"}
{"text": "[ 1 ] .Additional details about the analysis , such as null hypothesis and power calculation : .Cognitive change from baseline .[ 2 ] .", "label": "", "metadata": {}, "score": "82.94506"}
{"text": "[ 1 ] .Additional details about the analysis , such as null hypothesis and power calculation : .Cognitive change from baseline .[ 2 ] .", "label": "", "metadata": {}, "score": "82.94506"}
{"text": "[ 1 ] .Additional details about the analysis , such as null hypothesis and power calculation : .Cognitive change from baseline .[ 2 ] .", "label": "", "metadata": {}, "score": "82.94506"}
{"text": "Data on the population , study methods , and outcomes were extracted for each study independently by two reviewers .Discrepancies were resolved through discussion .", "label": "", "metadata": {}, "score": "83.11286"}
{"text": "Figure 2 : ( a ) Obesity and colon cancer in men .( b ) Obesity and colon cancer in women .Endometrial Cancer .", "label": "", "metadata": {}, "score": "83.24548"}
{"text": "For example , obese men have an increased risk of developing colon and renal ( RR both 1.57 ) , gallbladder ( 1.47 ) , pancreatic cancer ( 1.36 ) , and malignant melanoma ( 1.26 ) in comparison to nonobese men .", "label": "", "metadata": {}, "score": "83.250206"}
{"text": "Van Vliet HAAM , Winkel TA , Noort I , Rosing J , Rosendaal FR .Prothrombotic changes in users of combined oral contraceptives containing drospirenone and cyproterone acetate .", "label": "", "metadata": {}, "score": "83.340485"}
{"text": "Additional details about the analysis , such as null hypothesis and power calculation : .Role change , change from baseline .[ 2 ] .", "label": "", "metadata": {}, "score": "83.41852"}
{"text": "Renehan et al . reported a significant and positive association for the following five cancers that was not reported in this meta - analysis : leukemia , multiple myeloma , non - Hodgkin lymphoma , rectal , and thyroid cancer .", "label": "", "metadata": {}, "score": "83.4456"}
{"text": "What is already known on this topic .Combined oral contraceptives containing desogestrel , gestodene , and cyproterone acetate are associated with a higher risk of venous thromboembolism than levonorgestrel contraceptives .", "label": "", "metadata": {}, "score": "83.447784"}
{"text": "Additional details about the analysis , such as null hypothesis and power calculation : .Social change from baseline .[ 2 ] .Other relevant method information , such as adjustments or degrees of freedom : .", "label": "", "metadata": {}, "score": "83.529236"}
{"text": "Additional details about the analysis , such as null hypothesis and power calculation : .Social change from baseline .[ 2 ] .Other relevant method information , such as adjustments or degrees of freedom : .", "label": "", "metadata": {}, "score": "83.529236"}
{"text": "Additional details about the analysis , such as null hypothesis and power calculation : .Nausea and Vomiting change from baseline .[ 2 ] .", "label": "", "metadata": {}, "score": "83.62537"}
{"text": "The organization of this paper is as follows .In Section 2 , the theoretical background of the proposed confidence intervals is discussed .The investigations of the performance of the proposed confidence interval through a Monte Carlo simulation study are presented in Section 3 .", "label": "", "metadata": {}, "score": "83.70688"}
{"text": "562 - 571 , 2005 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .P. T. Katzmarzyk and I. Janssen , \" The economic costs associated with physical inactivity and obesity in Canada : an update , \" Canadian Journal of Applied Physiology , vol .", "label": "", "metadata": {}, "score": "83.71756"}
{"text": "Tests of heterogeneity were conducted among studies using a Chi square procedure , where . was considered an indication of heterogeneity .Risk ratios were pooled using the DerSimonian and Laird random effects model , given that there was considerable variation in how independent and dependent variables were measured across studies , and because in most cases statistically significant heterogeneity across study results was observed .", "label": "", "metadata": {}, "score": "83.762085"}
{"text": "Jick H , Jick SS , Gurewich V , Wald Myers M , Vasilakis C. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components .", "label": "", "metadata": {}, "score": "83.770294"}
{"text": "Additional details about the analysis , such as null hypothesis and power calculation : .Global quality of life change from baseline .[ 2 ] .", "label": "", "metadata": {}, "score": "83.77749"}
{"text": "We identified women who had a recorded diagnosis of venous thromboembolism ( deep vein thrombosis or pulmonary embolism ) after their entry into the cohort from the computer records , using the same Read and OXMIS codes as previously used in studies based on the General Practice Research Database .", "label": "", "metadata": {}, "score": "83.7789"}
{"text": "Billings et al .[ 6 ] used the coefficient of variation to study the impact of socioeconomic status on hospital use in New York City .", "label": "", "metadata": {}, "score": "83.81767"}
{"text": "Obese women are not only at higher risk for developing cancer at more sites than men , the risk associated with some of the cancers is significantly higher .", "label": "", "metadata": {}, "score": "83.94058"}
{"text": "In other words , the estimated coverage probabilities of existing confidence intervals tend to be too high .Additionally , the estimated coverage probabilities of existing confidence intervals increase as the values of .", "label": "", "metadata": {}, "score": "83.94536"}
{"text": "The most notable differences occurred for four cancers among men : renal , colon , pancreatic , and gallbladder cancer .For example , we reported a pooled risk ratio and 95 % confidence interval of 1.57 ( 1.38 , 1.77 ) for renal cancer , while Renehan et al . reported 1.24 ( 1.15 , 1.34 ) .", "label": "", "metadata": {}, "score": "83.978836"}
{"text": "Study Characteristics .The study designs included 43 cohort and 14 case - control studies published between 1985 and 2011 .The majority of studies were conducted in the United States ( 19 ) , followed by Sweden ( 7 ) , Norway ( 4 ) , and Japan ( 5 ) .", "label": "", "metadata": {}, "score": "83.98189"}
{"text": "[ 1 ] .Additional details about the analysis , such as null hypothesis and power calculation : .Social change from baseline .[ 2 ] .", "label": "", "metadata": {}, "score": "84.00605"}
{"text": "[ 1 ] .Additional details about the analysis , such as null hypothesis and power calculation : .Pain change from baseline .[ 2 ] .", "label": "", "metadata": {}, "score": "84.03552"}
{"text": "Measured Values .Ipilimumab Plus gp100 .Ipilimumab Monotherapy .gp100 .Number of Participants Analyzed [ units : participants ] .Statistical Analysis 1 for Change From Baseline in Health - Related Quality of Life ( QOL ) as Measured by the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire ( EORTC QLQ - C30 ) Instrument at Week 12 .", "label": "", "metadata": {}, "score": "84.09178"}
{"text": "World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception .Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease .", "label": "", "metadata": {}, "score": "84.09232"}
{"text": "The number of patients with IgG4-related retroperitoneal fibrosis without autoimmune pancreatitis , who visited hospitals in Japan in 2009 was approximately 272 ( 95 % confidence interval ; range 246 - 303 ) .", "label": "", "metadata": {}, "score": "84.268364"}
{"text": "Additional details about the analysis , such as null hypothesis and power calculation : .Appetite Loss change from baseline .[ 2 ] .Other relevant method information , such as adjustments or degrees of freedom : .", "label": "", "metadata": {}, "score": "84.270454"}
{"text": "Recall that with a normal distribution , 95 % of the distribution is within 1.96 standard deviations of the mean .Using the t distribution , if you have a sample size of only 5 , 95 % of the area is within 2.78 standard deviations of the mean .", "label": "", "metadata": {}, "score": "84.4577"}
{"text": "Controls came from the same general practices as cases and were matched on the number of years of recorded medical information , ensuring comparable quality and duration of information .", "label": "", "metadata": {}, "score": "84.53893"}
{"text": "According to this national survey of AIP , the number of AIP patients who visited a hospital in Japan in 2007 was estimated to be 2790 ( 95 % confidence interval ; range 2540 - 3040 ) .", "label": "", "metadata": {}, "score": "84.58171"}
{"text": "The death rate is 9.9 with a 95 % confidence interval from 6.6 to 14.8 and 6 average annual deaths .The rate is falling because the AAPC value is -3.6 with a 95 % confidence interval from -6.1 to -1.1 .", "label": "", "metadata": {}, "score": "84.843315"}
{"text": "Figure 1 shows this distribution .The shaded area represents the middle 95 % of the distribution and stretches from 66.48 to 113.52 .These limits were computed by adding and subtracting 1.96 standard deviations to / from the mean of 90 as follows : .", "label": "", "metadata": {}, "score": "85.007034"}
{"text": "The death rate is 10.7 with a 95 % confidence interval from 7.4 to 15.2 and 7 average annual deaths .The rate is falling because the AAPC value is -8.2 with a 95 % confidence interval from -12.5 to -3.8 .", "label": "", "metadata": {}, "score": "85.01083"}
{"text": "CONCLUSION :In this controlled trial involving patients with chronic PFPS , the outcome when arthroscopy was used in addition to a home exercise program was no better than when the home exercise program was used alone .", "label": "", "metadata": {}, "score": "85.06266"}
{"text": "CONCLUSION :In this controlled trial involving patients with chronic PFPS , the outcome when arthroscopy was used in addition to a home exercise program was no better than when the home exercise program was used alone .", "label": "", "metadata": {}, "score": "85.06266"}
{"text": "World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception .Venous thromboembolic disease and combined oral contraceptives : results of international multicentre case - control study .", "label": "", "metadata": {}, "score": "85.16579"}
{"text": "[ 1 ] .Additional details about the analysis , such as null hypothesis and power calculation : .Dyspnea change from baseline .[ 2 ] .", "label": "", "metadata": {}, "score": "85.28271"}
{"text": "[ 1 ] .Additional details about the analysis , such as null hypothesis and power calculation : .Dyspnea change from baseline .[ 2 ] .", "label": "", "metadata": {}, "score": "85.28271"}
{"text": "Where statistically significant associations are observed only one risk ratio is less than 20 % ( colon 1.19 ) , while the remaining risk ratios range between 1.25 ( postmenopausal breast ) , 1.32 ( leukemia ) , and 1.34 ( pancreatic ) .", "label": "", "metadata": {}, "score": "85.37751"}
{"text": "Studies deemed as being of weak methodological quality were excluded from further analysis as the validity of the results was questionable given the many limitations inherent in these studies .", "label": "", "metadata": {}, "score": "85.424805"}
{"text": "Funding :None .Ethical approval : The protocol for this study was approved by the Independent Scientific Advisory Committee for MHRA ( Medicines and Healthcare Products Regulatory Agency ) database research .", "label": "", "metadata": {}, "score": "85.43955"}
{"text": "Other evidence suggests that obesity leads to an increased risk for thirteen cancers including esophageal adenocarcinoma , thyroid , colon , rectal , renal , endometrial , pancreatic , gallbladder , postmenopausal breast , malignant melanoma , multiple myeloma , leukemia , and non - Hodgkin lymphoma [ 6 ] .", "label": "", "metadata": {}, "score": "85.59195"}
{"text": "Method [ 2 ] .ANCOVA .P Value [ 3 ] .Mean Difference ( Final Values ) [ 4 ] .95 % Confidence Interval . -2.8 to 9.5 .", "label": "", "metadata": {}, "score": "85.63122"}
{"text": "12 Secondary to this , failure to exclude people with other risk factors for the disease of interest can also result in a dilution of a real effect .", "label": "", "metadata": {}, "score": "85.674324"}
{"text": "Figure 10 : ( a ) Obesity and pancreatic cancer in men .( b ) Obesity and pancreatic cancer in women .Postmenopausal Breast Cancer .", "label": "", "metadata": {}, "score": "85.67784"}
{"text": "5 , pp .629 - 635 , 1983 .View at Google Scholar .L. H. Koopmans , D. B. Owen , and J. I. Rosenblatt , \" Confidence intervals for the coefficient of variation for the normal and lognormal distributions , \" Biometrika , vol .", "label": "", "metadata": {}, "score": "85.770485"}
{"text": "Population - attributable risk ( PAR ) is the portion of the incidence of a disease in the population that is due to exposure .PAR% is the percent of the incidence of a disease in the population that is due to exposure .", "label": "", "metadata": {}, "score": "85.788414"}
{"text": "Method [ 2 ] .ANCOVA .P Value [ 3 ] .Mean Difference ( Final Values ) [ 4 ] .95 % Confidence Interval . -2.5 to 8.6 .", "label": "", "metadata": {}, "score": "85.94984"}
{"text": "Method [ 2 ] .ANCOVA .P Value [ 3 ] .Mean Difference ( Final Values ) [ 4 ] .95 % Confidence Interval . -7.4 to 10.1 .", "label": "", "metadata": {}, "score": "86.00882"}
{"text": "Finally , of the 69 articles identified from the reference lists of relevant studies , 33 were deemed relevant .A total of 202 articles were deemed relevant for this paper .", "label": "", "metadata": {}, "score": "86.08274"}
{"text": "As can be seen from Figure 2 , McKay 's and Vangel 's confidence intervals have longer expected lengths than Miller 's and the proposed confidence intervals .", "label": "", "metadata": {}, "score": "86.11283"}
{"text": "Estimates of association were measured as a risk ratio and meta - analysis performed as a weighted average of the log risk ratios and 95 % confidence intervals .", "label": "", "metadata": {}, "score": "86.11781"}
{"text": "[ 1 ] .Additional details about the analysis , such as null hypothesis and power calculation : .Diarrhea change from baseline .[ 2 ] .", "label": "", "metadata": {}, "score": "86.18205"}
{"text": "[ 1 ] .Additional details about the analysis , such as null hypothesis and power calculation : .Diarrhea change from baseline .[ 2 ] .", "label": "", "metadata": {}, "score": "86.18205"}
{"text": "[ 1 ] .Additional details about the analysis , such as null hypothesis and power calculation : .Diarrhea change from baseline .[ 2 ] .", "label": "", "metadata": {}, "score": "86.18205"}
{"text": "[ 1 ] .Additional details about the analysis , such as null hypothesis and power calculation : .Constipation change from baseline .[ 2 ] .", "label": "", "metadata": {}, "score": "86.21402"}
{"text": "[ 1 ] .Additional details about the analysis , such as null hypothesis and power calculation : .Constipation change from baseline .[ 2 ] .", "label": "", "metadata": {}, "score": "86.21402"}
{"text": "We carried out all steps in the ascertainment of potential cases and selection of controls without knowledge of the particular study oral contraceptives women were taking .", "label": "", "metadata": {}, "score": "86.22496"}
{"text": "Method [ 2 ] .ANCOVA .P Value [ 3 ] .Mean Difference ( Final Values ) [ 4 ] .95 % Confidence Interval . -7.1 to 4.6 .", "label": "", "metadata": {}, "score": "86.296295"}
{"text": "Figure 6 : ( a ) Obesity and leukemia in men .( b ) Obesity and leukemia in women .Malignant Melanoma .Four studies assessed the association between obesity and malignant melanoma among men ( Figure 7(a ) ) and 3 among women ( Figure 7(b ) ) .", "label": "", "metadata": {}, "score": "86.30917"}
{"text": "Figure 7 : ( a ) Obesity and malignant melanoma in men .( b ) Obesity and malignant melanoma in women .Multiple Myeloma .", "label": "", "metadata": {}, "score": "86.45478"}
{"text": "This paper presents three confidence intervals for the coefficient of variation in a normal distribution with a known population mean .One of the proposed confidence intervals is based on the normal approximation .", "label": "", "metadata": {}, "score": "86.54445"}
{"text": "[ 1 ] .Additional details about the analysis , such as null hypothesis and power calculation : .Fatigue change from baseline .[ 2 ] .", "label": "", "metadata": {}, "score": "86.55831"}
{"text": "[ 1 ] .Additional details about the analysis , such as null hypothesis and power calculation : .Fatigue change from baseline .[ 2 ] .", "label": "", "metadata": {}, "score": "86.55831"}
{"text": "[ 1 ] .Additional details about the analysis , such as null hypothesis and power calculation : .Fatigue change from baseline .[ 2 ] .", "label": "", "metadata": {}, "score": "86.55831"}
{"text": "[ 1 ] .Additional details about the analysis , such as null hypothesis and power calculation : .Appetite loss change from baseline .[ 2 ] .", "label": "", "metadata": {}, "score": "86.57591"}
{"text": "[ 1 ] .Additional details about the analysis , such as null hypothesis and power calculation : .Appetite Loss change from baseline .[ 2 ] .", "label": "", "metadata": {}, "score": "86.57591"}
{"text": "Conclusions .The results of this meta - analysis illustrate a significant , positive , and , for some cancers , strong association between obesity and cancer incidence .", "label": "", "metadata": {}, "score": "86.58524"}
{"text": "Based on these results , the number of patients with Mikulicz 's disease without autoimmune pancreatitis who visited hospitals in Japan in 2009 , was approximately 4304 ( 95 % confidence interval ; range 3360 - 5048 ) ( Figure 2 ) .", "label": "", "metadata": {}, "score": "86.71449"}
{"text": "Method [ 2 ] .ANCOVA .P Value [ 3 ] .Mean Difference ( Final Values ) [ 4 ] .95 % Confidence Interval . -3.0 to 11.7 .", "label": "", "metadata": {}, "score": "86.82518"}
{"text": "[ 1 ] .Additional details about the analysis , such as null hypothesis and power calculation : .Nausea and Vomiting change from baseline .", "label": "", "metadata": {}, "score": "86.88274"}
{"text": "[ 1 ] .Additional details about the analysis , such as null hypothesis and power calculation : .Nausea and Vomiting change from baseline .", "label": "", "metadata": {}, "score": "86.88274"}
{"text": "6 , no . 1 - 2 , pp .132 - 137 , 2006 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . Y. Masaki , L. Dong , N. Kurose et al . , \" Proposal for a new clinical entity , IgG4-positive multiorgan lymphoproliferative syndrome : analysis of 64 cases of IgG4-related disorders , \" Annals of the Rheumatic Diseases , vol .", "label": "", "metadata": {}, "score": "86.925224"}
{"text": "From past research , we assume that the population mean of the weight of one - month old infants is about 4400 grams .An unbiased estimator of the coefficient of variation is .", "label": "", "metadata": {}, "score": "86.95451"}
{"text": "Method [ 2 ] .ANCOVA .P Value [ 3 ] .Mean Difference ( Final Values ) [ 4 ] .95 % Confidence Interval . -4.5 to 8.3 .", "label": "", "metadata": {}, "score": "87.06572"}
{"text": "Method [ 2 ] .ANCOVA .P Value [ 3 ] .Mean Difference ( Final Values ) [ 4 ] .95 % Confidence Interval . -8.1 to 5.2 .", "label": "", "metadata": {}, "score": "87.096306"}
{"text": "As an example to illustrate the use of meta - analysis results reported in this study , the PAR% for men and women in Canada was calculated on cancers for which a statistically significant association between obesity and cancer incidence was observed ( Table 2 ) .", "label": "", "metadata": {}, "score": "87.202446"}
{"text": "The number of patients with IgG4-related pulmonary disease without autoimmune pancreatitis , who visited hospitals in Japan in 2009 , was approximately 354 ( 95 % confidence interval ; range 283 - 424 ) .", "label": "", "metadata": {}, "score": "87.40309"}
{"text": "Figure 14 : ( a ) Obesity and thyroid cancer in men .( b ) Obesity and thyroid cancer in women .Results Summary .", "label": "", "metadata": {}, "score": "87.40401"}
{"text": "If you had wanted to compute the 99 % confidence interval , you would have set the shaded area to 0.99 and the result would have been 2.58 .", "label": "", "metadata": {}, "score": "87.58838"}
{"text": "Method [ 2 ] .ANCOVA .P Value [ 3 ] .Mean Difference ( Final Values ) [ 4 ] .95 % Confidence Interval . -7.9 to 4.2 .", "label": "", "metadata": {}, "score": "87.65721"}
{"text": "R. L. Graham , D. E. Knuth , and O. Patashink , Answer to Problem 9.60 in Concrete Mathematics : A Foundation for Computer Science , Addison - Wesley , Reading , Pa , USA , 1994 .", "label": "", "metadata": {}, "score": "87.68768"}
{"text": "There was significant heterogeneity across studies ( heterogeneity .Esophageal Adenocarcinoma .There were 3 studies that assessed the association between obesity and esophageal adenocarcinoma in men ( Figure 4(a ) ) and 4 studies among women ( Figure 4(b ) ) .", "label": "", "metadata": {}, "score": "87.71724"}
{"text": "Introduction .Chronic diseases are the leading cause of mortality and morbidity and contribute significantly to the overall health expenditures from both a societal perspective as well as an individual one [ 1 ] .", "label": "", "metadata": {}, "score": "87.81259"}
{"text": "Method [ 2 ] .ANCOVA .P Value [ 3 ] .Mean Difference ( Final Values ) [ 4 ] .95 % Confidence Interval . -8.7 to 4.2 .", "label": "", "metadata": {}, "score": "87.94481"}
{"text": "Figure 13 : ( a ) Obesity and renal cancer in men .( b ) Obesity and renal cancer in women .Thyroid Cancer .", "label": "", "metadata": {}, "score": "87.94971"}
{"text": "Scopus database , 1989 - 2011 ) .Blacks / African Americans experienced both a higher number and magnitude of disparities than any other group in the analyses .", "label": "", "metadata": {}, "score": "87.9624"}
{"text": "Three confidence intervals for the coefficient of variation in a normal distribution with a known population mean have been developed .The proposed confidence intervals are compared with Miller 's , McKay 's , and Vangel 's confidence intervals through a Monte Carlo simulation study .", "label": "", "metadata": {}, "score": "87.981"}
{"text": "The number of patients with IgG4-related renal disease without autoimmune pancreatitis , who visited hospitals in Japan in 2009 , was approximately 57 ( 95 % confidence interval ; range 47 - 66 ) .", "label": "", "metadata": {}, "score": "88.14079"}
{"text": "Additional details about the analysis , such as null hypothesis and power calculation : .Constipation change from baseline .[ 2 ] .Other relevant method information , such as adjustments or degrees of freedom : .", "label": "", "metadata": {}, "score": "88.26492"}
{"text": "[ 1 ] .Additional details about the analysis , such as null hypothesis and power calculation : .Physical change from baseline .[ 2 ] .", "label": "", "metadata": {}, "score": "88.26924"}
{"text": "[ 1 ] .Additional details about the analysis , such as null hypothesis and power calculation : .Physical change from baseline .[ 2 ] .", "label": "", "metadata": {}, "score": "88.26924"}
{"text": "[ 1 ] .Additional details about the analysis , such as null hypothesis and power calculation : .Physical change from baseline .[ 2 ] .", "label": "", "metadata": {}, "score": "88.26924"}
{"text": "1310 - 1315 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . H. Umehara , K. Okazaki , Y. Masaki et al . , \" A novel clinical entity , IgG4-related disease ( IgG4RD)-general concept and details , \" Modern Rheumatology , vol .", "label": "", "metadata": {}, "score": "88.65996"}
{"text": "Furthermore , 37 departments in hospitals in a particular stratum which were considered to have recorded AIP cases for research purposes and 317 departments in university hospitals were stratified separately .", "label": "", "metadata": {}, "score": "88.91599"}
{"text": "No .Population Description .Explanation of how the number of participants for analysis was determined .Includes whether analysis was per protocol , intention to treat , or another method .", "label": "", "metadata": {}, "score": "89.10855"}
{"text": "Rising when 95 % confidence interval of average annual percent change is above 0 .Stable when 95 % confidence interval of average annual percent change includes 0 .", "label": "", "metadata": {}, "score": "89.188286"}
{"text": "Method [ 2 ] .ANCOVA .P Value [ 3 ] .Mean Difference ( Final Values ) [ 4 ] .95 % Confidence Interval . -12.8 to 0.3 .", "label": "", "metadata": {}, "score": "89.38649"}
{"text": "There are several possibilities of reasons for this matter .In this survey , we estimated the number of IgG4-RD patients based on the hospitals ' treatment of AIP .", "label": "", "metadata": {}, "score": "89.58768"}
{"text": "Obesity is defined as a Body Mass Index ( BMI ) of 30 kg / m 2 or greater .Approximately a quarter of Canadian men and women are considered obese [ 9 ] .", "label": "", "metadata": {}, "score": "89.653854"}
{"text": "Methodological Quality Assessment .All studies judged to be relevant were assessed for methodological quality by two independent reviewers using an existing quality assessment tool , based on the work of the Evidence - based Medicine group at McMaster University .", "label": "", "metadata": {}, "score": "89.6768"}
{"text": "Method [ 2 ] .ANCOVA .P Value [ 3 ] .Mean Difference ( Final Values ) [ 4 ] .95 % Confidence Interval .", "label": "", "metadata": {}, "score": "89.73005"}
{"text": "Method [ 2 ] .ANCOVA .P Value [ 3 ] .Mean Difference ( Final Values ) [ 4 ] .95 % Confidence Interval .", "label": "", "metadata": {}, "score": "89.73005"}
{"text": "Method [ 2 ] .ANCOVA .P Value [ 3 ] .Mean Difference ( Final Values ) [ 4 ] .95 % Confidence Interval .", "label": "", "metadata": {}, "score": "89.73005"}
{"text": "Method [ 2 ] .ANCOVA .P Value [ 3 ] .Mean Difference ( Final Values ) [ 4 ] .95 % Confidence Interval .", "label": "", "metadata": {}, "score": "89.73005"}
{"text": "Method [ 2 ] .ANCOVA .P Value [ 3 ] .Mean Difference ( Final Values ) [ 4 ] .95 % Confidence Interval .", "label": "", "metadata": {}, "score": "89.73005"}
{"text": "Method [ 2 ] .ANCOVA .P Value [ 3 ] .Mean Difference ( Final Values ) [ 4 ] .95 % Confidence Interval .", "label": "", "metadata": {}, "score": "89.73005"}
{"text": "Method [ 2 ] .ANCOVA .P Value [ 3 ] .Mean Difference ( Final Values ) [ 4 ] .95 % Confidence Interval .", "label": "", "metadata": {}, "score": "89.73005"}
{"text": "Method [ 2 ] .ANCOVA .P Value [ 3 ] .Mean Difference ( Final Values ) [ 4 ] .95 % Confidence Interval .", "label": "", "metadata": {}, "score": "89.73005"}
{"text": "Method [ 2 ] .ANCOVA .P Value [ 3 ] .Mean Difference ( Final Values ) [ 4 ] .95 % Confidence Interval .", "label": "", "metadata": {}, "score": "89.73005"}
{"text": "Method [ 2 ] .ANCOVA .P Value [ 3 ] .Mean Difference ( Final Values ) [ 4 ] .95 % Confidence Interval .", "label": "", "metadata": {}, "score": "89.73005"}
{"text": "Method [ 2 ] .ANCOVA .P Value [ 3 ] .Mean Difference ( Final Values ) [ 4 ] .95 % Confidence Interval .", "label": "", "metadata": {}, "score": "89.73005"}
{"text": "Method [ 2 ] .ANCOVA .P Value [ 3 ] .Mean Difference ( Final Values ) [ 4 ] .95 % Confidence Interval .", "label": "", "metadata": {}, "score": "89.73005"}
{"text": "Method [ 2 ] .ANCOVA .P Value [ 3 ] .Mean Difference ( Final Values ) [ 4 ] .95 % Confidence Interval .", "label": "", "metadata": {}, "score": "89.73005"}
{"text": "Method [ 2 ] .ANCOVA .P Value [ 3 ] .Mean Difference ( Final Values ) [ 4 ] .95 % Confidence Interval .", "label": "", "metadata": {}, "score": "89.73005"}
{"text": "Method [ 2 ] .ANCOVA .P Value [ 3 ] .Mean Difference ( Final Values ) [ 4 ] .95 % Confidence Interval .", "label": "", "metadata": {}, "score": "89.73005"}
{"text": "Method [ 2 ] .ANCOVA .P Value [ 3 ] .Mean Difference ( Final Values ) [ 4 ] .95 % Confidence Interval .", "label": "", "metadata": {}, "score": "89.73005"}
{"text": "Method [ 2 ] .ANCOVA .P Value [ 3 ] .Mean Difference ( Final Values ) [ 4 ] .95 % Confidence Interval .", "label": "", "metadata": {}, "score": "89.73005"}
{"text": "Method [ 2 ] .ANCOVA .P Value [ 3 ] .Mean Difference ( Final Values ) [ 4 ] .95 % Confidence Interval .", "label": "", "metadata": {}, "score": "89.73005"}
{"text": "Method [ 2 ] .ANCOVA .P Value [ 3 ] .Mean Difference ( Final Values ) [ 4 ] .95 % Confidence Interval .", "label": "", "metadata": {}, "score": "89.73005"}
{"text": "Method [ 2 ] .ANCOVA .P Value [ 3 ] .Mean Difference ( Final Values ) [ 4 ] .95 % Confidence Interval .", "label": "", "metadata": {}, "score": "89.73005"}
{"text": "Method [ 2 ] .ANCOVA .P Value [ 3 ] .Mean Difference ( Final Values ) [ 4 ] .95 % Confidence Interval .", "label": "", "metadata": {}, "score": "89.73005"}
{"text": "Method [ 2 ] .ANCOVA .P Value [ 3 ] .Mean Difference ( Final Values ) [ 4 ] .95 % Confidence Interval .", "label": "", "metadata": {}, "score": "89.73005"}
{"text": "Method [ 2 ] .ANCOVA .P Value [ 3 ] .Mean Difference ( Final Values ) [ 4 ] .95 % Confidence Interval .", "label": "", "metadata": {}, "score": "89.73005"}
{"text": "Method [ 2 ] .ANCOVA .P Value [ 3 ] .Mean Difference ( Final Values ) [ 4 ] .95 % Confidence Interval .", "label": "", "metadata": {}, "score": "89.73005"}
{"text": "Method [ 2 ] .ANCOVA .P Value [ 3 ] .Mean Difference ( Final Values ) [ 4 ] .95 % Confidence Interval .", "label": "", "metadata": {}, "score": "89.73005"}
{"text": "Method [ 2 ] .ANCOVA .P Value [ 3 ] .Mean Difference ( Final Values ) [ 4 ] .95 % Confidence Interval .", "label": "", "metadata": {}, "score": "89.73005"}
{"text": "Method [ 2 ] .ANCOVA .P Value [ 3 ] .Mean Difference ( Final Values ) [ 4 ] .95 % Confidence Interval .", "label": "", "metadata": {}, "score": "89.73005"}
{"text": "Method [ 2 ] .ANCOVA .P Value [ 3 ] .Mean Difference ( Final Values ) [ 4 ] .95 % Confidence Interval .", "label": "", "metadata": {}, "score": "89.73005"}
{"text": "Method [ 2 ] .ANCOVA .P Value [ 3 ] .Mean Difference ( Final Values ) [ 4 ] .95 % Confidence Interval .", "label": "", "metadata": {}, "score": "89.73005"}
{"text": "Method [ 2 ] .ANCOVA .P Value [ 3 ] .Mean Difference ( Final Values ) [ 4 ] .95 % Confidence Interval .", "label": "", "metadata": {}, "score": "89.73005"}
{"text": "Method [ 2 ] .ANCOVA .P Value [ 3 ] .Mean Difference ( Final Values ) [ 4 ] .95 % Confidence Interval .", "label": "", "metadata": {}, "score": "89.73005"}
{"text": "Method [ 2 ] .ANCOVA .P Value [ 3 ] .Mean Difference ( Final Values ) [ 4 ] .95 % Confidence Interval .", "label": "", "metadata": {}, "score": "89.73005"}
{"text": "Method [ 2 ] .ANCOVA .P Value [ 3 ] .Mean Difference ( Final Values ) [ 4 ] .95 % Confidence Interval .", "label": "", "metadata": {}, "score": "89.73005"}
{"text": "Method [ 2 ] .ANCOVA .P Value [ 3 ] .Mean Difference ( Final Values ) [ 4 ] .95 % Confidence Interval .", "label": "", "metadata": {}, "score": "89.73005"}
{"text": "Method [ 2 ] .ANCOVA .P Value [ 3 ] .Mean Difference ( Final Values ) [ 4 ] .95 % Confidence Interval .", "label": "", "metadata": {}, "score": "89.73005"}
{"text": "when random variables are not independently and identically distributed .Recent work of Gulhar et al .[28 ] has compared several confidence intervals for estimating the population coefficient of variation based on parametric , nonparametric , and modified methods .", "label": "", "metadata": {}, "score": "89.82639"}
{"text": "Furthermore , Pyne et al .[ 8 ] studied the variability of the competitive performance of Olympic swimmers by using the coefficient of variation .", "label": "", "metadata": {}, "score": "89.84319"}
{"text": "[ 1 ] .Additional details about the analysis , such as null hypothesis and power calculation : .Financial Impact change from baseline .[ 2 ] .", "label": "", "metadata": {}, "score": "90.302765"}
{"text": "[ 1 ] .Additional details about the analysis , such as null hypothesis and power calculation : .Financial Impact change from baseline .[ 2 ] .", "label": "", "metadata": {}, "score": "90.302765"}
{"text": "[ 1 ] .Additional details about the analysis , such as null hypothesis and power calculation : .Financial Impact change from baseline .[ 2 ] .", "label": "", "metadata": {}, "score": "90.302765"}
{"text": "45 - 68 , 2012 .View at Google Scholar .J. A. Rice , Mathematical Statistics and Data Analysis , Duxbury Press , Belmont , Calif , USA , 2006 .", "label": "", "metadata": {}, "score": "90.49652"}
{"text": "The number of patients with autoimmune pancreatitis who visited hospitals in Japan in 2007 was approximately 2709 ( 95 % confidence interval ; range 2540 - 3040 ) .", "label": "", "metadata": {}, "score": "90.6009"}
{"text": "The values of t to be used in a confidence interval can be looked up in a table of the t distribution .A small version of such a table is shown in Table 1 .", "label": "", "metadata": {}, "score": "90.69047"}
{"text": "Two reviewers independently screened all retrieved articles using an existing relevance assessment tool .Both reviewers independently assessed each study for relevance and met to resolve discrepancies through discussion .", "label": "", "metadata": {}, "score": "90.828636"}
{"text": "The electronic searches performed by Renehan et al .were replicated from January 2007 to May 2011 in Medline and Embase through OVID .Titles and abstracts were screened for relevance by two independent reviewers .", "label": "", "metadata": {}, "score": "90.93475"}
{"text": "Explanation of how the number of participants for analysis was determined .Includes whether analysis was per protocol , intention to treat , or another method .", "label": "", "metadata": {}, "score": "91.20485"}
{"text": "19 We used Stata version 11.0 for all analyses .We estimated incidence rates and age standardised rate ratios by using Stata version 11.0 and Episheet .", "label": "", "metadata": {}, "score": "91.441666"}
{"text": "Faber and Korn [ 4 ] applied the coefficient of variation as a way of including a measure of variation in the mean synaptic response of the central nervous system .", "label": "", "metadata": {}, "score": "91.54343"}
{"text": "Bloemenkamp KWM , Rosendaal FR , Helmerhorst FM , B\u00fcller HR , Vandenbroucke JP .Enhancement by factor V Leiden mutation of risk of deep - vein thrombosis associated with oral contraceptives containing a third - generation progestagen .", "label": "", "metadata": {}, "score": "91.61709"}
{"text": "A significant association was not observed among women for malignant melanoma , multiple myeloma , non - Hodgkin lymphoma , rectal cancer , and thyroid cancer .", "label": "", "metadata": {}, "score": "91.810616"}
{"text": "All scores were linearly transformed to a 0 to 100 scale .Time Frame .Baseline ( Day 1 , Cycle1 ) , Week 12 .", "label": "", "metadata": {}, "score": "91.82979"}
{"text": "This is one of several nationwide surveys conducted to elucidate the number of AIP patients in Japan and also the first such survey to be conducted worldwide .", "label": "", "metadata": {}, "score": "91.91705"}
{"text": "Conclusions are provided in the final section .Theoretical Results .In this section , the mean and variance of the estimator of the coefficient of variation in a normal distribution with a known population mean are considered .", "label": "", "metadata": {}, "score": "92.12345"}
{"text": "Suppose the following five were sampled from a normal distribution with a standard deviation of 2.5 : 2 , 3 , 5 , 6 , and 9 .", "label": "", "metadata": {}, "score": "92.459366"}
{"text": "The mean time difference for all 47 subjects is 16.362 seconds and the standard deviation is 7.470 seconds .The standard error of the mean is 1.090 .", "label": "", "metadata": {}, "score": "92.51227"}
{"text": "Methods .Search Strategy .Several activities were included in the search strategy to identify primary studies for this paper .An overview of the review process is depicted in Figure 1 .", "label": "", "metadata": {}, "score": "92.85852"}
{"text": "Figure 1 .The middle 95 % of the distribution is shaded .Figure 1 shows that 95 % of the means are no more than 23.52 units ( 1.96 standard deviations ) from the mean of 90 .", "label": "", "metadata": {}, "score": "92.87661"}
{"text": "82 , no . 2 , pp .449 - 452 , 1999 .View at Google Scholar \u00b7 View at Scopus . A. J. Hammer , J. R. Strachan , M. M. Black , C. Ibbotson , and R. A. Elson , \" A new method of comparative bone strength measurement , \" Journal of Medical Engineering and Technology , vol .", "label": "", "metadata": {}, "score": "93.07441"}
{"text": "We will finish with an analysis of the Stroop Data .Specifically , we will compute a confidence interval on the mean difference score .Recall that 47 subjects named the color of ink that color words were written in .", "label": "", "metadata": {}, "score": "93.11535"}
{"text": "When you compute a confidence interval , you compute the mean of a sample in order to estimate the mean of the population .Clearly , if you already knew the population mean , there would be no need for a confidence interval .", "label": "", "metadata": {}, "score": "93.212425"}
{"text": "Van Hylckama Vlieg A , Helmerhorst FM , Vandenbroucke JP , Doggen CJM , Rosendaal FR .The venous thrombotic risk of oral contraceptives , effects of oestrogen dose and progestogen type : results of the MEGA case - control study .", "label": "", "metadata": {}, "score": "93.34174"}
{"text": "View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . E. G. Miller and M. J. Karson , \" Testing the equality of two coefficients of variation , \" in American Statistical Association : Proceedings of the Business and Economics Section , Part I , pp .", "label": "", "metadata": {}, "score": "93.786095"}
{"text": "The primary outcome was the Kujala score on patellofemoral pain and function at 9 months following randomization .Secondary outcomes were visual analog scales ( VASs ) to assess activity - related symptoms .", "label": "", "metadata": {}, "score": "93.79419"}
{"text": "The primary outcome was the Kujala score on patellofemoral pain and function at 9 months following randomization .Secondary outcomes were visual analog scales ( VASs ) to assess activity - related symptoms .", "label": "", "metadata": {}, "score": "93.79419"}
{"text": "did not report a significant and positive association for gallbladder and pancreatic cancer whereas a significant and positive association was reported in this paper .There was greater similarity between the results of this paper and Renehan et al . for women .", "label": "", "metadata": {}, "score": "93.86037"}
{"text": "Figure 4 : ( a ) Obesity and esophageal adenocarcinoma in men .( b ) Obesity and esophageal adenocarcinoma in women .Gallbladder Cancer .", "label": "", "metadata": {}, "score": "94.144775"}
{"text": "M1c : The cancer has spread to other organs and/or locations in the body with or without elevated LDH .[ 3 ] .Upper limit of normal ( ULN ) was 250 U / L for most assessments ( some variation caused by tests performed at local laboratories ) .", "label": "", "metadata": {}, "score": "94.23985"}
{"text": "For example the risk ratio is as high as 1.77 for renal cancer , 1.73 for pancreatic cancer and 1.65 for colon cancer .Even at the low end of the 95 % confidence interval , cancer risk is still noteworthy at 1.48 for colon cancer , and 1.38 for renal cancer .", "label": "", "metadata": {}, "score": "94.61985"}
{"text": "J. Ledolter and R. V. Hogg , Applied Statistics for Engineers and Physical Scientists , Pearson , New Jersey , NJ , USA , 2010 .", "label": "", "metadata": {}, "score": "94.742325"}
{"text": "Data provided are for informational purposes only .Although carefully collected , accuracy can not be guaranteed .The impact factor represents a rough estimation of the journal 's impact factor and does not reflect the actual current impact factor .", "label": "", "metadata": {}, "score": "94.905716"}
{"text": "Differing provisions from the publisher 's actual policy or licence agreement may be applicable .Kettunen , J. , Harilainen , A. , Sandelin , J. , Schlenzka , D. , Hietaniemi , K. , Seitsalo , S. , Malmivaara , A. & Kujala , U. ( 2007 ) .", "label": "", "metadata": {}, "score": "94.949066"}
{"text": "The first steps are to compute the sample mean and variance : .The next step is to estimate the standard error of the mean .", "label": "", "metadata": {}, "score": "95.15557"}
{"text": "All subjects who received at least 1 dose or any partial dose of study medication .Reporting Groups .Description .Ipilimumab Plus gp100 .Ipilimumab was administered at a dosage of 3 mg / kg as an intravenous ( IV ) infusion administered over 90 minutes every 3 weeks for a total of 4 doses , together with gp100 .", "label": "", "metadata": {}, "score": "95.23856"}
{"text": "For women the greatest benefits from obesity reduction and prevention efforts would be observed for esophageal adenocarcinoma , endometrial , gallbladder , renal , pancreatic , leukemia , postmenopausal breast , and colon cancer .", "label": "", "metadata": {}, "score": "95.25925"}
{"text": "Main outcome measures Odds ratios and 95 % confidence intervals estimated with conditional logistic regression ; age adjusted incidence rate ratio estimated with Poisson regression .", "label": "", "metadata": {}, "score": "95.40684"}
{"text": "No text entered .Reporting Groups .Description .Ipilimumab Plus gp100 .Ipilimumab was administered at a dosage of 3 mg / kg as an intravenous ( IV ) infusion administered over 90 minutes every 3 weeks for a total of 4 doses , together with gp100 .", "label": "", "metadata": {}, "score": "95.47415"}
{"text": "However , a rigorous and systematic meta - analysis process should not limit study inclusion by the country in which the study was conducted .As a result a decision was made to be more rather than less inclusive .", "label": "", "metadata": {}, "score": "95.529785"}
{"text": "Ipilimumab Monotherapy .Ipilimumab was administered at a dosage of 3 mg / kg as an intravenous ( IV ) infusion administered over 90 minutes every 3 weeks for a total of 4 doses , together with matching vaccine placebo .", "label": "", "metadata": {}, "score": "95.570564"}
{"text": "Ipilimumab Monotherapy .Ipilimumab was administered at a dosage of 3 mg / kg as an intravenous ( IV ) infusion administered over 90 minutes every 3 weeks for a total of 4 doses , together with matching vaccine placebo .", "label": "", "metadata": {}, "score": "95.570564"}
{"text": "Ipilimumab Monotherapy .Ipilimumab was administered at a dosage of 3 mg / kg as an intravenous ( IV ) infusion administered over 90 minutes every 3 weeks for a total of 4 doses , together with matching vaccine placebo .", "label": "", "metadata": {}, "score": "95.570564"}
{"text": "In general , you compute the 95 % confidence interval for the mean with the following formula : . where Z .95 is the number of standard deviations extending from the mean of a normal distribution required to contain 0.95 of the area and \u03c3 m is the standard error of the mean .", "label": "", "metadata": {}, "score": "95.79595"}
{"text": "Conclusions .These findings have important implications for public health practice globally as well as Canada .First , the evidence reported here continues to establish the evidence base suggesting a statistically significant and positive association between obesity and cancer risk .", "label": "", "metadata": {}, "score": "95.83136"}
{"text": "To estimate the number of patients with IgG4-related disease in Japan , we randomly selected hospitals using stratification and asked them how many patients they had with IgG4-related disease in 2009 .", "label": "", "metadata": {}, "score": "95.948"}
{"text": "6 , pp .585 - 587 , 2002 .View at Google Scholar . Y. Ohno , The Nationwide Epidemiological Survey Manual For Investigating the Number of Patients and Clinico - Epidemiological Features of Intractable Diseases , Japanese Ministry of Health and Welfare , Tokyo , Japan , 1998 . H. Umehara , K. Okazaki , Y. Masaki et al . , \" Comprehensive diagnostic criteria for IgG4-related disease ( IgG4-RD ) , \" Modern Rheumatology , vol .", "label": "", "metadata": {}, "score": "96.04082"}
{"text": "Among men PAR% ranged from a low of 5.6 % to a high of 11.5 % .The PAR% for obesity among men was greatest for colon and renal cancer ( 11.5 % ) , gallbladder cancer ( 9.7 % ) , pancreatic ( 7.6 % ) , and malignant melanoma ( 5.6 % ) .", "label": "", "metadata": {}, "score": "96.12077"}
{"text": "N. Buntao and S. Niwitpong , \" Confidence intervals for the difference of coefficients of variation for lognormal distributions and delta - lognormal distributions , \" Applied Mathematical Sciences , vol .", "label": "", "metadata": {}, "score": "96.2718"}
{"text": "It seemed that patients with IgG4-related disease gathered a lot in these 250 hospitals .This survey included questions about sex , age of disease onset , and the diagnostic basis for IgG4-RD .", "label": "", "metadata": {}, "score": "96.43425"}
{"text": "Among women a statistically significant increased risk of cancer was observed for the following 8 cancers : colon , endometrial , esophageal , gallbladder , leukemia , pancreatic , postmenopausal breast , and renal .", "label": "", "metadata": {}, "score": "96.874374"}
{"text": "21 - 30 , 2012 .View at Google Scholar 2 Boston Collaborative Drug Surveillance Program , Boston University School of Medicine , 11 Muzzey Street , Lexington , MA 02421 , USA .", "label": "", "metadata": {}, "score": "96.90709"}
{"text": "R. Ihaka and R. Gentleman , \" R : a language for data analysis and graphics , \" Journal of Computational and Graphical Statistics , vol .", "label": "", "metadata": {}, "score": "96.96571"}
{"text": "25 - 32 , 1964 .View at Google Scholar .S. Verrill , \" Confidence bounds for normal and log - normal distribution coefficient of variation , \" Research Paper EPL - RP-609 , U. S. Department of Agriculture , Madison , Wis , USA , 2003 .", "label": "", "metadata": {}, "score": "97.04032"}
{"text": "Other relevant method information , such as adjustments or degrees of freedom : .No text entered .[ 3 ] .Additional information , such as whether or not the p - value is adjusted for multiple comparisons and the a priori threshold for statistical significance : .", "label": "", "metadata": {}, "score": "97.120026"}
{"text": "Other relevant method information , such as adjustments or degrees of freedom : .No text entered .[ 3 ] .Additional information , such as whether or not the p - value is adjusted for multiple comparisons and the a priori threshold for statistical significance : .", "label": "", "metadata": {}, "score": "97.120026"}
{"text": "Other relevant method information , such as adjustments or degrees of freedom : .No text entered .[ 3 ] .Additional information , such as whether or not the p - value is adjusted for multiple comparisons and the a priori threshold for statistical significance : .", "label": "", "metadata": {}, "score": "97.120026"}
{"text": "Other relevant method information , such as adjustments or degrees of freedom : .No text entered .[ 3 ] .Additional information , such as whether or not the p - value is adjusted for multiple comparisons and the a priori threshold for statistical significance : .", "label": "", "metadata": {}, "score": "97.120026"}
{"text": "Other relevant method information , such as adjustments or degrees of freedom : .No text entered .[ 3 ] .Additional information , such as whether or not the p - value is adjusted for multiple comparisons and the a priori threshold for statistical significance : .", "label": "", "metadata": {}, "score": "97.120026"}
{"text": "Other relevant method information , such as adjustments or degrees of freedom : .No text entered .[ 3 ] .Additional information , such as whether or not the p - value is adjusted for multiple comparisons and the a priori threshold for statistical significance : .", "label": "", "metadata": {}, "score": "97.120026"}
{"text": "It is important to note that the results from some of the studies included in this paper may not be relevant to a Canadian context .", "label": "", "metadata": {}, "score": "97.16904"}
{"text": "RKH contributed to the conduct of the analyses , the interpretation of the results , and the manuscript .All authors had full access to all of the data ( including statistical reports and tables ) in the study and can take responsibility for the integrity of the data and the accuracy of the data analysis .", "label": "", "metadata": {}, "score": "97.25874"}
{"text": "Z .95 can be found using the normal distribution calculator and specifying that the shaded area is 0.95 and indicating that you want the area to be between the cutoff points .", "label": "", "metadata": {}, "score": "97.86084"}
{"text": "Thus , it has been estimated that there are approximately 6,700 to 26,000 patients in Japan who have developed IgG4-RD over the past 20 years .", "label": "", "metadata": {}, "score": "97.88356"}
{"text": "Figure 2 : Mikulicz ' disease without autoimmune pancreatitis .The number of patients with Mikulicz 's disease without autoimmune pancreatitis , who visited hospitals in Japan in 2009 , was approximately 4304 ( 95 % confidence interval ; range 3360 - 5048 ) .", "label": "", "metadata": {}, "score": "98.0708"}
{"text": "[ 24 ] and Verrill [ 25 ] .Buntao and Niwitpong [ 26 ] also introduced an interval estimating the difference of the coefficient of variation for lognormal and delta - lognormal distributions .", "label": "", "metadata": {}, "score": "98.11049"}
{"text": "Figure 5 : ( a ) Obesity and gallbladder cancer in men .( b ) Obesity and gallbladder cancer in women .Leukemia .There were 2 studies that assessed the association between obesity and leukemia among men ( Figure 6(a ) ) and women ( Figure 6(b ) ) .", "label": "", "metadata": {}, "score": "98.29468"}
{"text": "Sagadahoc County .The death rate is 12.7 with a 95 % confidence interval from 8.6 to 18.4 and 6 average annual deaths .The rate is falling because the AAPC value is -5.5 with a 95 % confidence interval from -7.7 to -3.2 .", "label": "", "metadata": {}, "score": "98.39281"}
{"text": "Sharma and Krishna [ 20 ] introduced the asymptotic distribution and confidence interval of the reciprocal of the coefficient of variation which does not require any assumptions about the population distribution to be made .", "label": "", "metadata": {}, "score": "98.41394"}
{"text": "From these two national surveys , it is suggested that total number of patients with IgG4-related disease including autoimmune pancreatitis in Japan was approximately about 10,000 and the average of age of disease onset was 58 years .", "label": "", "metadata": {}, "score": "98.60018"}
{"text": "No text entered .[ 3 ] .Additional information , such as whether or not the p - value is adjusted for multiple comparisons and the a priori threshold for statistical significance : .", "label": "", "metadata": {}, "score": "98.62457"}
{"text": "No text entered .[ 3 ] .Additional information , such as whether or not the p - value is adjusted for multiple comparisons and the a priori threshold for statistical significance : .", "label": "", "metadata": {}, "score": "98.62457"}
{"text": "No text entered .[ 3 ] .Additional information , such as whether or not the p - value is adjusted for multiple comparisons and the a priori threshold for statistical significance : .", "label": "", "metadata": {}, "score": "98.62457"}
{"text": "No text entered .[ 3 ] .Additional information , such as whether or not the p - value is adjusted for multiple comparisons and the a priori threshold for statistical significance : .", "label": "", "metadata": {}, "score": "98.62457"}
{"text": "No text entered .[ 3 ] .Additional information , such as whether or not the p - value is adjusted for multiple comparisons and the a priori threshold for statistical significance : .", "label": "", "metadata": {}, "score": "98.62457"}
{"text": "No text entered .[ 3 ] .Additional information , such as whether or not the p - value is adjusted for multiple comparisons and the a priori threshold for statistical significance : .", "label": "", "metadata": {}, "score": "98.62457"}
{"text": "No text entered .[ 3 ] .Additional information , such as whether or not the p - value is adjusted for multiple comparisons and the a priori threshold for statistical significance : .", "label": "", "metadata": {}, "score": "98.62457"}
{"text": "No text entered .[ 3 ] .Additional information , such as whether or not the p - value is adjusted for multiple comparisons and the a priori threshold for statistical significance : .", "label": "", "metadata": {}, "score": "98.62457"}
{"text": "No text entered .[ 3 ] .Additional information , such as whether or not the p - value is adjusted for multiple comparisons and the a priori threshold for statistical significance : .", "label": "", "metadata": {}, "score": "98.62457"}
{"text": "No text entered .[ 3 ] .Additional information , such as whether or not the p - value is adjusted for multiple comparisons and the a priori threshold for statistical significance : .", "label": "", "metadata": {}, "score": "98.62457"}
{"text": "No text entered .[ 3 ] .Additional information , such as whether or not the p - value is adjusted for multiple comparisons and the a priori threshold for statistical significance : .", "label": "", "metadata": {}, "score": "98.62457"}
{"text": "No text entered .[ 3 ] .Additional information , such as whether or not the p - value is adjusted for multiple comparisons and the a priori threshold for statistical significance : .", "label": "", "metadata": {}, "score": "98.62457"}
{"text": "No text entered .[ 3 ] .Additional information , such as whether or not the p - value is adjusted for multiple comparisons and the a priori threshold for statistical significance : .", "label": "", "metadata": {}, "score": "98.62457"}
{"text": "No text entered .[ 3 ] .Additional information , such as whether or not the p - value is adjusted for multiple comparisons and the a priori threshold for statistical significance : .", "label": "", "metadata": {}, "score": "98.62457"}
{"text": "No text entered .[ 3 ] .Additional information , such as whether or not the p - value is adjusted for multiple comparisons and the a priori threshold for statistical significance : .", "label": "", "metadata": {}, "score": "98.62457"}
{"text": "No text entered .[ 3 ] .Additional information , such as whether or not the p - value is adjusted for multiple comparisons and the a priori threshold for statistical significance : .", "label": "", "metadata": {}, "score": "98.62457"}
{"text": "No text entered .[ 3 ] .Additional information , such as whether or not the p - value is adjusted for multiple comparisons and the a priori threshold for statistical significance : .", "label": "", "metadata": {}, "score": "98.62457"}
{"text": "No text entered .[ 3 ] .Additional information , such as whether or not the p - value is adjusted for multiple comparisons and the a priori threshold for statistical significance : .", "label": "", "metadata": {}, "score": "98.62457"}
{"text": "No text entered .[ 3 ] .Additional information , such as whether or not the p - value is adjusted for multiple comparisons and the a priori threshold for statistical significance : .", "label": "", "metadata": {}, "score": "98.62457"}
{"text": "No text entered .[ 3 ] .Additional information , such as whether or not the p - value is adjusted for multiple comparisons and the a priori threshold for statistical significance : .", "label": "", "metadata": {}, "score": "98.62457"}
{"text": "No text entered .[ 3 ] .Additional information , such as whether or not the p - value is adjusted for multiple comparisons and the a priori threshold for statistical significance : .", "label": "", "metadata": {}, "score": "98.62457"}
{"text": "No text entered .[ 3 ] .Additional information , such as whether or not the p - value is adjusted for multiple comparisons and the a priori threshold for statistical significance : .", "label": "", "metadata": {}, "score": "98.62457"}
{"text": "No text entered .[ 3 ] .Additional information , such as whether or not the p - value is adjusted for multiple comparisons and the a priori threshold for statistical significance : .", "label": "", "metadata": {}, "score": "98.62457"}
{"text": "No text entered .[ 3 ] .Additional information , such as whether or not the p - value is adjusted for multiple comparisons and the a priori threshold for statistical significance : .", "label": "", "metadata": {}, "score": "98.62457"}
{"text": "No text entered .[ 3 ] .Additional information , such as whether or not the p - value is adjusted for multiple comparisons and the a priori threshold for statistical significance : .", "label": "", "metadata": {}, "score": "98.62457"}
{"text": "No text entered .[ 3 ] .Additional information , such as whether or not the p - value is adjusted for multiple comparisons and the a priori threshold for statistical significance : .", "label": "", "metadata": {}, "score": "98.62457"}
{"text": "No text entered .[ 3 ] .Additional information , such as whether or not the p - value is adjusted for multiple comparisons and the a priori threshold for statistical significance : .", "label": "", "metadata": {}, "score": "98.62457"}
{"text": "No text entered .[ 3 ] .Additional information , such as whether or not the p - value is adjusted for multiple comparisons and the a priori threshold for statistical significance : .", "label": "", "metadata": {}, "score": "98.62457"}
{"text": "No text entered .[ 3 ] .Additional information , such as whether or not the p - value is adjusted for multiple comparisons and the a priori threshold for statistical significance : .", "label": "", "metadata": {}, "score": "98.62457"}
{"text": "No text entered .[ 3 ] .Additional information , such as whether or not the p - value is adjusted for multiple comparisons and the a priori threshold for statistical significance : .", "label": "", "metadata": {}, "score": "98.62457"}
{"text": "No text entered .[ 3 ] .Additional information , such as whether or not the p - value is adjusted for multiple comparisons and the a priori threshold for statistical significance : .", "label": "", "metadata": {}, "score": "98.62457"}
{"text": "No text entered .[ 3 ] .Additional information , such as whether or not the p - value is adjusted for multiple comparisons and the a priori threshold for statistical significance : .", "label": "", "metadata": {}, "score": "98.62457"}
{"text": "State Cancer Registries may provide more current or more local data .Data presented on the State Cancer Profiles Web Site may differ from statistics reported by the State Cancer Registries ( for more information ) .", "label": "", "metadata": {}, "score": "98.78203"}
{"text": "Figure 3 : ( a ) Histogram , ( b ) density plot , ( c ) Box - and - Whisker plot , and ( d ) normal quantile - quantile plot of the weights of 61 one - month old infants .", "label": "", "metadata": {}, "score": "98.795456"}
{"text": "The coefficient of variation has been widely used in many areas such as science , medicine , engineering , economics , and others .For example , the coefficient of variation has also been employed by Ahn [ 2 ] to analyze the uncertainty of fault trees .", "label": "", "metadata": {}, "score": "98.92282"}
{"text": "Ipilimumab was administered at a dosage of 3 mg / kg as an intravenous ( IV ) infusion administered over 90 minutes every 3 weeks for a total of 4 doses , together with gp100 .", "label": "", "metadata": {}, "score": "99.126785"}
{"text": "One had a basilic vein thrombosis that was thought to have an anatomical cause ; the remaining three had confirmed venous thromboembolism with predisposing conditions ( antiphospholipid syndrome , major trauma , prolonged immobility ) .", "label": "", "metadata": {}, "score": "99.16707"}
{"text": "In this survey , the male : female ratio was 1 : 0.77 .Most patients have Mikulicz 's disease without autoimmune pancreatitis .In Mikulicz 's disease , the male : female ratio was 1.30 : 1 .", "label": "", "metadata": {}, "score": "99.182144"}
{"text": "In Ishikawa Prefecture , there are two University Hospitals , Kanazawa Medical University Hospital and Kanazawa University Hospital .Assuming that new patients with IgG4-RD would visit one of the two university hospitals , it was estimated that the incidence of this disease throughout Japan is 0.28 - 1.08/100,000 population with 336 - 1,300 patients newly diagnosed per year from 2003 to 2009 .", "label": "", "metadata": {}, "score": "99.243225"}
{"text": "This may sound unrealistic , and it is .However , computing a confidence interval when \u03c3 is known is easier than when \u03c3 has to be estimated , and serves a pedagogical purpose .", "label": "", "metadata": {}, "score": "99.31239"}
{"text": "The next step is to find the value of t. The confidence interval is then computed just as it is when \u03c3 m .The only differences are that s m and t rather than \u03c3 m and Z are used .", "label": "", "metadata": {}, "score": "99.37332"}
{"text": "Equal - Tailed Confidence Interval .Simulation Study .A Monte Carlo simulation was conducted using the R statistical software [ 34 - 36 ] version 3.0.1 to investigate the estimated coverage probabilities and expected lengths of three proposed confidence intervals and to compare them to the existing confidence intervals .", "label": "", "metadata": {}, "score": "99.42103"}
{"text": "His confidence interval is based on an analysis of the distribution of a class of approximate pivotal quantities for the normal coefficient of variation .In addition , modified McKay 's confidence interval is closely related to McKay 's confidence interval but it is usually more accurate and nearly exact under normality .", "label": "", "metadata": {}, "score": "99.471565"}
{"text": "Stable when 95 % confidence interval of average annual percent change includes 0 .Falling when 95 % confidence interval of average annual percent change is below 0 .", "label": "", "metadata": {}, "score": "99.50087"}
{"text": "Among men a statistically significant increased risk of cancer was observed for the following 5 cancers : colon , gallbladder , malignant melanoma , pancreatic , and renal cancer .", "label": "", "metadata": {}, "score": "99.5475"}
{"text": "25 - 32 , 2002 .View at Google Scholar . A. T. McKay , \" Distribution of the coefficient of variation and the extended t distribution , \" Journal of the Royal Statistics Society , vol .", "label": "", "metadata": {}, "score": "99.57724"}
{"text": "Answer rate of this survey is not so high .One reason is guessed that IgG4-RD is not familiarized , therefore the patients with IgG4-RD are concentrated on the hospital that answered this survey .", "label": "", "metadata": {}, "score": "99.62893"}
{"text": "Results .Search Results .In total 141 articles were identified from Renehan et al . , 1723 from the database searches and 69 from reference lists ; the total is 1933 papers .", "label": "", "metadata": {}, "score": "99.65413"}
{"text": "[ 3 ] .Additional information , such as whether or not the p - value is adjusted for multiple comparisons and the a priori threshold for statistical significance : .", "label": "", "metadata": {}, "score": "99.72627"}
{"text": "[ 3 ] .Additional information , such as whether or not the p - value is adjusted for multiple comparisons and the a priori threshold for statistical significance : .", "label": "", "metadata": {}, "score": "99.72627"}
{"text": "[ 3 ] .Additional information , such as whether or not the p - value is adjusted for multiple comparisons and the a priori threshold for statistical significance : .", "label": "", "metadata": {}, "score": "99.72627"}
{"text": "[ 3 ] .Additional information , such as whether or not the p - value is adjusted for multiple comparisons and the a priori threshold for statistical significance : .", "label": "", "metadata": {}, "score": "99.72627"}
{"text": "[ 3 ] .Additional information , such as whether or not the p - value is adjusted for multiple comparisons and the a priori threshold for statistical significance : .", "label": "", "metadata": {}, "score": "99.72627"}
{"text": "[ 3 ] .Additional information , such as whether or not the p - value is adjusted for multiple comparisons and the a priori threshold for statistical significance : .", "label": "", "metadata": {}, "score": "99.72627"}
{"text": "[ 3 ] .Additional information , such as whether or not the p - value is adjusted for multiple comparisons and the a priori threshold for statistical significance : .", "label": "", "metadata": {}, "score": "99.72627"}
{"text": "Drug : MDX-010 ( anti - CTLA4 ) monoclonal antibody Biological : MDX-1379 ( gp100 )Melanoma Peptide Vaccine .Key information relevant to the recruitment process for the overall study , such as dates of the recruitment period and locations .", "label": "", "metadata": {}, "score": "99.76022"}
{"text": "The population - attributable risk percent for obesity in Canada was highest in men for five cancers : colon , renal , gallbladder , pancreatic , and malignant melanoma .", "label": "", "metadata": {}, "score": "99.77203"}
{"text": "Each peptide was prepared with Montanide ISA-51 .One dose of gp100 consisted of the administration of Peptide A , at a dosage of 2 mL or 1 mg , and Peptide B , at a dosage of 2 mL or 1 mg .", "label": "", "metadata": {}, "score": "99.83018"}
{"text": "Each peptide was prepared with Montanide ISA-51 .One dose of gp100 consisted of the administration of Peptide A , at a dosage of 2 mL or 1 mg , and Peptide B , at a dosage of 2 mL or 1 mg .", "label": "", "metadata": {}, "score": "99.83018"}
{"text": "Each peptide was prepared with Montanide ISA-51 .One dose of gp100 consisted of the administration of Peptide A , at a dosage of 2 mL or 1 mg , and Peptide B , at a dosage of 2 mL or 1 mg .", "label": "", "metadata": {}, "score": "99.83018"}
{"text": "[ 4 ] .Other relevant estimation information : .Least square mean can be defined as a linear combination of estimated effects , from a linear model .", "label": "", "metadata": {}, "score": "100.1548"}
{"text": "[ 4 ] .Other relevant estimation information : .Least square mean can be defined as a linear combination of estimated effects , from a linear model .", "label": "", "metadata": {}, "score": "100.1548"}
{"text": "[ 4 ] .Other relevant estimation information : .Least square mean can be defined as a linear combination of estimated effects , from a linear model .", "label": "", "metadata": {}, "score": "100.1548"}
{"text": "[ 4 ] .Other relevant estimation information : .Least square mean can be defined as a linear combination of estimated effects , from a linear model .", "label": "", "metadata": {}, "score": "100.1548"}
{"text": "[ 4 ] .Other relevant estimation information : .Least square mean can be defined as a linear combination of estimated effects , from a linear model .", "label": "", "metadata": {}, "score": "100.1548"}
{"text": "[ 4 ] .Other relevant estimation information : .Least square mean can be defined as a linear combination of estimated effects , from a linear model .", "label": "", "metadata": {}, "score": "100.1548"}
{"text": "[ 4 ] .Other relevant estimation information : .Least square mean can be defined as a linear combination of estimated effects , from a linear model .", "label": "", "metadata": {}, "score": "100.1548"}
{"text": "[ 4 ] .Other relevant estimation information : .Least square mean can be defined as a linear combination of estimated effects , from a linear model .", "label": "", "metadata": {}, "score": "100.1548"}
{"text": "[ 4 ] .Other relevant estimation information : .Least square mean can be defined as a linear combination of estimated effects , from a linear model .", "label": "", "metadata": {}, "score": "100.1548"}
{"text": "[ 4 ] .Other relevant estimation information : .Least square mean can be defined as a linear combination of estimated effects , from a linear model .", "label": "", "metadata": {}, "score": "100.1548"}
{"text": "[ 4 ] .Other relevant estimation information : .Least square mean can be defined as a linear combination of estimated effects , from a linear model .", "label": "", "metadata": {}, "score": "100.1548"}
{"text": "[ 4 ] .Other relevant estimation information : .Least square mean can be defined as a linear combination of estimated effects , from a linear model .", "label": "", "metadata": {}, "score": "100.1548"}
{"text": "[ 4 ] .Other relevant estimation information : .Least square mean can be defined as a linear combination of estimated effects , from a linear model .", "label": "", "metadata": {}, "score": "100.1548"}
{"text": "[ 4 ] .Other relevant estimation information : .Least square mean can be defined as a linear combination of estimated effects , from a linear model .", "label": "", "metadata": {}, "score": "100.1548"}
{"text": "[ 4 ] .Other relevant estimation information : .Least square mean can be defined as a linear combination of estimated effects , from a linear model .", "label": "", "metadata": {}, "score": "100.1548"}
{"text": "[ 4 ] .Other relevant estimation information : .Least square mean can be defined as a linear combination of estimated effects , from a linear model .", "label": "", "metadata": {}, "score": "100.1548"}
{"text": "[ 4 ] .Other relevant estimation information : .Least square mean can be defined as a linear combination of estimated effects , from a linear model .", "label": "", "metadata": {}, "score": "100.1548"}
{"text": "[ 4 ] .Other relevant estimation information : .Least square mean can be defined as a linear combination of estimated effects , from a linear model .", "label": "", "metadata": {}, "score": "100.1548"}
{"text": "[ 4 ] .Other relevant estimation information : .Least square mean can be defined as a linear combination of estimated effects , from a linear model .", "label": "", "metadata": {}, "score": "100.1548"}
{"text": "[ 4 ] .Other relevant estimation information : .Least square mean can be defined as a linear combination of estimated effects , from a linear model .", "label": "", "metadata": {}, "score": "100.1548"}
{"text": "[ 4 ] .Other relevant estimation information : .Least square mean can be defined as a linear combination of estimated effects , from a linear model .", "label": "", "metadata": {}, "score": "100.1548"}
{"text": "[ 4 ] .Other relevant estimation information : .Least square mean can be defined as a linear combination of estimated effects , from a linear model .", "label": "", "metadata": {}, "score": "100.1548"}
{"text": "[ 4 ] .Other relevant estimation information : .Least square mean can be defined as a linear combination of estimated effects , from a linear model .", "label": "", "metadata": {}, "score": "100.1548"}
{"text": "[ 4 ] .Other relevant estimation information : .Least square mean can be defined as a linear combination of estimated effects , from a linear model .", "label": "", "metadata": {}, "score": "100.1548"}
{"text": "[ 4 ] .Other relevant estimation information : .Least square mean can be defined as a linear combination of estimated effects , from a linear model .", "label": "", "metadata": {}, "score": "100.1548"}
{"text": "[ 4 ] .Other relevant estimation information : .Least square mean can be defined as a linear combination of estimated effects , from a linear model .", "label": "", "metadata": {}, "score": "100.1548"}
{"text": "[ 4 ] .Other relevant estimation information : .Least square mean can be defined as a linear combination of estimated effects , from a linear model .", "label": "", "metadata": {}, "score": "100.1548"}
{"text": "[ 4 ] .Other relevant estimation information : .Least square mean can be defined as a linear combination of estimated effects , from a linear model .", "label": "", "metadata": {}, "score": "100.1548"}
{"text": "[ 4 ] .Other relevant estimation information : .Least square mean can be defined as a linear combination of estimated effects , from a linear model .", "label": "", "metadata": {}, "score": "100.1548"}
{"text": "[ 4 ] .Other relevant estimation information : .Least square mean can be defined as a linear combination of estimated effects , from a linear model .", "label": "", "metadata": {}, "score": "100.1548"}
{"text": "[ 4 ] .Other relevant estimation information : .Least square mean can be defined as a linear combination of estimated effects , from a linear model .", "label": "", "metadata": {}, "score": "100.1548"}
{"text": "[ 4 ] .Other relevant estimation information : .Least square mean can be defined as a linear combination of estimated effects , from a linear model .", "label": "", "metadata": {}, "score": "100.1548"}
{"text": "[ 4 ] .Other relevant estimation information : .Least square mean can be defined as a linear combination of estimated effects , from a linear model .", "label": "", "metadata": {}, "score": "100.1548"}
{"text": "[ 4 ] .Other relevant estimation information : .Least square mean can be defined as a linear combination of estimated effects , from a linear model .", "label": "", "metadata": {}, "score": "100.1548"}
{"text": "[ 4 ] .Other relevant estimation information : .Least square mean can be defined as a linear combination of estimated effects , from a linear model .", "label": "", "metadata": {}, "score": "100.1548"}
{"text": "[ 4 ] .Other relevant estimation information : .Least square mean can be defined as a linear combination of estimated effects , from a linear model .", "label": "", "metadata": {}, "score": "100.1548"}
{"text": "[ 4 ] .Other relevant estimation information : .Least square mean can be defined as a linear combination of estimated effects , from a linear model .", "label": "", "metadata": {}, "score": "100.1548"}
{"text": "[ 4 ] .Other relevant estimation information : .Least square mean can be defined as a linear combination of estimated effects , from a linear model .", "label": "", "metadata": {}, "score": "100.1548"}
{"text": "[ 4 ] .Other relevant estimation information : .Least square mean can be defined as a linear combination of estimated effects , from a linear model .", "label": "", "metadata": {}, "score": "100.1548"}
{"text": "[ 4 ] .Other relevant estimation information : .Least square mean can be defined as a linear combination of estimated effects , from a linear model .", "label": "", "metadata": {}, "score": "100.1548"}
{"text": "[ 4 ] .Other relevant estimation information : .Least square mean can be defined as a linear combination of estimated effects , from a linear model .", "label": "", "metadata": {}, "score": "100.1548"}
{"text": "[ 4 ] .Other relevant estimation information : .Least square mean can be defined as a linear combination of estimated effects , from a linear model .", "label": "", "metadata": {}, "score": "100.1548"}
{"text": "[ 4 ] .Other relevant estimation information : .Least square mean can be defined as a linear combination of estimated effects , from a linear model .", "label": "", "metadata": {}, "score": "100.1548"}
{"text": "[ 4 ] .Other relevant estimation information : .Least square mean can be defined as a linear combination of estimated effects , from a linear model .", "label": "", "metadata": {}, "score": "100.1548"}
{"text": "[ 4 ] .Other relevant estimation information : .Least square mean can be defined as a linear combination of estimated effects , from a linear model .", "label": "", "metadata": {}, "score": "100.1548"}
{"text": "The male : female ratio was 1 : 0.77 , and the average of age of disease onset was 58.8 years .The total number of patients with IgG4-related disease in Japan in 2009 , including autoimmune pancreatitis , was approximately 8000 .", "label": "", "metadata": {}, "score": "100.340256"}
{"text": "Winter M , Keeling D , Sharpen F , Cohen H , Vallance P , for the Haemostasis and Thrombosis Task Force of the British Committee for Standards in Haematology .", "label": "", "metadata": {}, "score": "101.13719"}
{"text": "You can also use the \" inverse t distribution \" calculator to find the t values to use in confidence intervals .You will learn more about the t distribution in the next section .", "label": "", "metadata": {}, "score": "101.329155"}
{"text": "SSJ was involved in the conception and design of the study , obtained data for and oversaw the conduct of the study , and contributed to the interpretation of the results and the writing of the manuscript .", "label": "", "metadata": {}, "score": "101.678696"}
{"text": "Therefore , the interference effect ( difference ) for the whole population is likely to be between 14.17 and 18.56 seconds .", "label": "", "metadata": {}, "score": "102.436195"}
{"text": "The coefficient of variation of a distribution is a dimensionless number that quantifies the degree of variability relative to the mean [ 1 ] .It is a statistical measure for comparing the dispersion of several variables obtained by different units .", "label": "", "metadata": {}, "score": "102.78891"}
{"text": "Cite this as : BMJ 2011;342:d2139 .Footnotes .We thank David Skegg and Charlotte Paul for their helpful comments on an earlier draft of the paper and Sheila Williams for help with implementing multiple imputation methods in Stata .", "label": "", "metadata": {}, "score": "102.82012"}
{"text": "One dose of gp100 consisted of the administration of Peptide A , at a dosage of 2 mL or 1 mg , and Peptide B , at a dosage of 2 mL or 1 mg .", "label": "", "metadata": {}, "score": "103.65525"}
{"text": "One dose of gp100 consisted of the administration of Peptide A , at a dosage of 2 mL or 1 mg , and Peptide B , at a dosage of 2 mL or 1 mg .", "label": "", "metadata": {}, "score": "103.65525"}
{"text": "One dose of gp100 consisted of the administration of Peptide A , at a dosage of 2 mL or 1 mg , and Peptide B , at a dosage of 2 mL or 1 mg .", "label": "", "metadata": {}, "score": "103.65525"}
{"text": "4 , pp .695 - 698 , 1932 .View at Publisher \u00b7 View at Google Scholar . E. C. Fieller , \" A numerical test of the adequacy of A.T. McKay 's approximation , \" Journal of the Royal Statistical Society , vol .", "label": "", "metadata": {}, "score": "103.82635"}
{"text": "12 , no . 1 , pp .166 - 169 , 1970 .View at Google Scholar . E. S. Pearson , \" Comparison of A.T. McKay 's approximation with experimental sampling results , \" Journal of the Royal Statistics Society , vol .", "label": "", "metadata": {}, "score": "103.864685"}
{"text": "We conducted a national survey for IgG4-RD , based on a national survey for AIP in 2009 .Methods .In 2006 , the Japan Pancreas Society first proposed the diagnostic criteria for AIP [ 10 , 11 ] .", "label": "", "metadata": {}, "score": "103.95111"}
{"text": "Confidence Intervals for the Coefficient of Variation in a Normal Distribution with a Known Population Mean .Department of Mathematics and Statistics , Faculty of Science and Technology , Thammasat University , Phathum Thani 12120 , Thailand .", "label": "", "metadata": {}, "score": "104.56343"}
{"text": "Another national survey in Japan was reported by Umehara et al .[ 9 ] .They have estimated the number of individuals with IgG4-RD throughout Japan by using the number of patients in Ishikawa Prefecture as an example .", "label": "", "metadata": {}, "score": "104.702385"}
{"text": "BACKGROUND : Arthroscopy is often used to treat patients with chronic patellofemoral pain syndrome ( PFPS ) .As there is a lack of evidence , we conducted a randomized controlled trial to study the efficacy of arthroscopy in patients with chronic PFPS .", "label": "", "metadata": {}, "score": "104.93796"}
{"text": "Knee arthroscopy and exercise versus exercise only for chronic patellofemoral pain syndrome : a randomized controlled trial .BMC Medicine , 5 : 38 .Title : .", "label": "", "metadata": {}, "score": "105.52185"}
{"text": "Allocation : Randomized ; Endpoint Classification : Safety / Efficacy Study ; Intervention Model : Parallel Assignment ; Masking : Double Blind ( Subject , Caregiver , Investigator ) ; Primary Purpose : Treatment .", "label": "", "metadata": {}, "score": "105.52385"}
{"text": "When the sample size is large , say 100 or above , the t distribution is very similar to the standard normal distribution .However , with smaller sample sizes , the t distribution is leptokurtic , which means it has relatively more scores in its tails than does the normal distribution .", "label": "", "metadata": {}, "score": "105.640884"}
{"text": "The number of AIP patients who visited a hospital in Japan was estimated to be 2790 patients .Therefore , the total number of patients with IgG4-related disease including autoimmune pancreatitis in Japan in 2009 was approximately 8000 .", "label": "", "metadata": {}, "score": "105.997055"}
{"text": "371 , no .9612 , pp .569 - 578 , 2008 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .", "label": "", "metadata": {}, "score": "106.131096"}
{"text": "BMC Medicine , 5 : 38 .BACKGROUND : Arthroscopy is often used to treat patients with chronic patellofemoral pain syndrome ( PFPS ) .As there is a lack of evidence , we conducted a randomized controlled trial to study the efficacy of arthroscopy in patients with chronic PFPS .", "label": "", "metadata": {}, "score": "106.496124"}
{"text": "Prevalence of IgG4-Related Disease in Japan Based on Nationwide Survey in 2009 . 1 Division of Gastroenterology and Hepatology , The Third Department of Internal Medicine , Kansai Medical University , 2 - 3 - 1 Shinmachi , Hirakata , Osaka 573 - 1197 , Japan 2 Department of Gastroenterology , Tohoku University Graduate School of Medicine , Seiryo - Cho , Obaku , Sendai 980 - 8514 , Japan .", "label": "", "metadata": {}, "score": "106.52049"}
{"text": "[ 2 ] .The \" M \" in the TNM ( tumor , node , metastasis ) system refers to distant metastases - whether , and how far , the cancer has spread outside the original site .", "label": "", "metadata": {}, "score": "107.43109"}
{"text": "Conclusions .The coefficient of variation is the ratio of standard deviation to the mean and provides a widely used unit - free measure of dispersion .", "label": "", "metadata": {}, "score": "107.56348"}
{"text": "[ 37 ] ( cited in Ledolter and Hogg [ 38 ] , page 287 ) .The histogram , density plot , Box - and - Whisker plot , and normal quantile - quantile plot are displayed in Figure 3 .", "label": "", "metadata": {}, "score": "107.82154"}
{"text": "4 , pp .703 - 704 , 1932 .View at Google Scholar .G. J. Umphrey , \" A comment on McKay 's approximation for the coefficient of variation , \" Communications in Statistics - Simulation and Computation , vol .", "label": "", "metadata": {}, "score": "108.295135"}
{"text": "Author : .Kettunen , Jyrki A. ; Harilainen , Arsi ; Sandelin , Jerker ; Schlenzka , Dietrich ; Hietaniemi , Kalevi ; Seitsalo , Seppo ; Malmivaara , Antti ; Kujala , Urho M. .", "label": "", "metadata": {}, "score": "108.49147"}
{"text": "46 , no . 3 , pp .277 - 288 , 2011 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .", "label": "", "metadata": {}, "score": "108.51161"}
{"text": "40 , no . 3 , pp .352 - 358 , 2011 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .", "label": "", "metadata": {}, "score": "109.00723"}
{"text": "40 , no . 7 , pp .1561 - 1568 , 1995 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .", "label": "", "metadata": {}, "score": "109.0671"}
{"text": "Type 1 AIP is characterized by IgG4 .On the other hand , type 2 AIP is characterized by neutrophil infiltration .Type 1 AIP is commonly complicated with other organ involvement ( OOI ) [ 4 , 5 ] .", "label": "", "metadata": {}, "score": "109.14502"}
{"text": "proposed autoimmune pancreatitis ( AIP ) [ 1 ] .Hamano et al . reported that these patients showed elevated serum IgG4 [ 2 ] .", "label": "", "metadata": {}, "score": "109.17169"}
{"text": "Conflict of Interests .The author declares that there is no conflict of interests regarding the publication of this paper .Acknowledgments .The author is grateful to Professor Dr. Tonghui Wang , Professor Dr. John J. Borkowski , and anonymous referees for their valuable comments and suggestions , which have significantly enhanced the quality and presentation of this paper .", "label": "", "metadata": {}, "score": "109.22485"}
{"text": "proposed IgG4-related sclerosing disease [ 6 ] .This concept is based on sclerosing fibrosis .Systemic IgG4-related plasmacytic syndrome ( SIPS ) and IgG4-positive multiorgan lymphoproliferative syndrome ( IgG4-MOLPS ) were proposed based on lymphoproliferation [ 7 , 8 ] .", "label": "", "metadata": {}, "score": "110.250595"}
{"text": "IgG4-related disease ( IgG4-RD ) has recently been proposed as a new disease entity , and a number of case reports and studies evaluating the clinical characteristics of IgG4-RD have appeared in the literature .", "label": "", "metadata": {}, "score": "110.6768"}
{"text": "After Week 12 , subjects who met re - induction criteria could receive further cycles of their randomized study therapy .gp100 .Gp100 consisted of 2 separate peptide components : Peptide A , a peptide with sequence YLEPGPVTV ( gp100:280 - 288[288V ] ) and Peptide B , a peptide with the sequence IMDQVPFSV ( gp100:209 - 217[210 M ] ) .", "label": "", "metadata": {}, "score": "110.71551"}
{"text": "After Week 12 , subjects who met re - induction criteria could receive further cycles of their randomized study therapy .gp100 .Gp100 consisted of 2 separate peptide components : Peptide A , a peptide with sequence YLEPGPVTV ( gp100:280 - 288[288V ] ) and Peptide B , a peptide with the sequence IMDQVPFSV ( gp100:209 - 217[210 M ] ) .", "label": "", "metadata": {}, "score": "110.71551"}
{"text": "After Week 12 , subjects who met re - induction criteria could receive further cycles of their randomized study therapy .gp100 .Gp100 consisted of 2 separate peptide components : Peptide A , a peptide with sequence YLEPGPVTV ( gp100:280 - 288[288V ] ) and Peptide B , a peptide with the sequence IMDQVPFSV ( gp100:209 - 217[210 M ] ) .", "label": "", "metadata": {}, "score": "110.71551"}
{"text": "299 - 314 , 1996 .View at Google Scholar \u00b7 View at Scopus .R Development Core Team , An Introduction to R , R Foundation for Statistical Computing , Vienna , Austria , 2013 .", "label": "", "metadata": {}, "score": "111.62248"}
{"text": "It will be necessary to familiarize general physicians with this new disease concept .Acknowledgments .References .K. Yoshida , F. Toki , T. Takeuchi , S. I. Watanabe , K. Shiratori , and N. Hayashi , \" Chronic pancreatitis caused by an autoimmune abnormality .", "label": "", "metadata": {}, "score": "111.78879"}
{"text": "The most common OOIs are the well - known Mikulicz 's disease , IgG4-related retroperitoneal fibrosis , IgG4-related renal disease , IgG4-related pulmonary disease , and IgG4-related lymphadenopathy .", "label": "", "metadata": {}, "score": "112.091736"}
{"text": "Log in or register : .Download this article to citation manager .Parkin Lianne , Sharples Katrina , Hernandez Rohini K , Jick Susan S .", "label": "", "metadata": {}, "score": "112.48486"}
{"text": "The correct response is to say \" red \" and ignore the fact that the word is \" blue .\" Each subject named the ink color of 60 words and their times in seconds were recorded .", "label": "", "metadata": {}, "score": "114.64206"}
{"text": "A concerted strategy is needed to reduce pain care disparities within the larger quality of care initiatives .[ Show abstract ] [ Hide abstract ] ABSTRACT :", "label": "", "metadata": {}, "score": "115.2073"}
{"text": "M1 : The cancer has spread beyond the original site .M1a : The cancer has spread to other areas of skin , underneath the epidermis to the dermis ( subcutaneous ) , or to lymph node(s ) .", "label": "", "metadata": {}, "score": "118.89191"}
{"text": "Recall from the section on the sampling distribution of the mean that the mean of the sampling distribution is \u03bc and the standard error of the mean is .", "label": "", "metadata": {}, "score": "121.18789"}
{"text": "4 , pp .699 - 702 , 1932 .View at Google Scholar .B. Iglewicz , Some properties of the coefficient of variation [ Ph.D. thesis ] , Virginia Polytechnic Institute , Blacksburg , Va , USA , 1967 .", "label": "", "metadata": {}, "score": "121.75504"}
{"text": "View at Google Scholar .Members of the Criteria Committee for Autoimmune Pancreatitis of the Japan Pancreas Society , \" Diagnostic criteria for autoimmune pancreatitis by the Japan Pancreas Society , \" Journal of The Japan Pancreas Society , vol .", "label": "", "metadata": {}, "score": "125.72515"}
{"text": "1 School of Nursing , McMaster University , 1280 Main Street West , 3N25 G , Hamilton , ON , Canada L8N 3Z5 2 Department of Epidemiology and Community Medicine , University of Ottawa , Ottawa , ON , Canada K1H 8M5 .", "label": "", "metadata": {}, "score": "128.43008"}
{"text": "Academic Editors : C. R. Gonz\u00e1lez Bonilla , C. Grandjean , and F. Mawas .Copyright \u00a9 2013 M. Dobbins et al .This is an open access article distributed under the Creative Commons Attribution License , which permits unrestricted use , distribution , and reproduction in any medium , provided the original work is properly cited .", "label": "", "metadata": {}, "score": "131.31879"}
{"text": "Academic Editor : Vikram Deshpande .Copyright \u00a9 2012 Kazushige Uchida et al .This is an open access article distributed under the Creative Commons Attribution License , which permits unrestricted use , distribution , and reproduction in any medium , provided the original work is properly cited .", "label": "", "metadata": {}, "score": "154.83994"}
{"text": "Copyright \u00a9 2013 Wararit Panichkitkosolkul .This is an open access article distributed under the Creative Commons Attribution License , which permits unrestricted use , distribution , and reproduction in any medium , provided the original work is properly cited .", "label": "", "metadata": {}, "score": "156.18127"}
